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ABSTRACT 
Many people with Parkinson’s disease fall frequently and recurrently. The consequences 
of falls can be devastating, far reaching and costly. Unfortunately, medications for 
Parkinson’s disease do not appear to prevent falls. The overall aim of the studies in this 
thesis was to evaluate and explore exercise interventions with the potential to reduce fall 
risk in people with Parkinson’s disease. 
 
Leg muscle weakness, freezing of gait and reduced balance are risk factors for falls 
which are potentially remediable with exercise in people with Parkinson’s disease. 
However, there is a paucity of research into the effects of exercise training on fall risk in 
this group. A randomised controlled trial with blinded assessment was conducted to 
assess the effect on fall risk of a six-month exercise program which targeted these risk 
factors compared with usual care in people with Parkinson’s disease. Forty-eight 
participants with Parkinson’s disease who had fallen or were at risk of falling were 
randomised to the exercise or control group. The exercise group attended a monthly 
exercise class and performed exercises at home, such that exercises were performed 
three times per week. Both groups received falls prevention advice. The primary 
outcome measure was a Parkinson’s disease fall risk score (% risk of falling) – an 
algorithm consisting of weighted contributions from knee extensor muscle strength of 
the weaker leg, balance in standing and freezing of gait. Secondary outcome measures 
included measures of the targeted risk factors as well as physical abilities, fear of falling 
and quality of life. The exercise group showed a 7% greater improvement than the 
control group in the Parkinson’s disease falls risk score, but this was not statistically 
significant (95% Confidence Interval (95% CI) -20 to 5) and the clinical relevance of 
this small reduction is uncertain. There were statistically significant improvements in the 
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exercise group compared to the control group for two secondary outcomes which were 
not part of the falls risk score: Freezing of Gait Questionnaire (mean between-group 
difference = -2.8, 95% CI -5.4 to -0.3) and timed sit to stand (mean between-group 
difference = -1.9 s, 95% CI -3.6 to -0.2).  There were non-significant trends toward 
greater improvements in the exercise group for other measures that were not part of the 
falls risk score, including muscle strength (stronger leg P = 0.06), fast walking speed (P 
= 0.21) and fear of falling (P = 0.10), but not for balance or quality of life.  The exercise 
group had no major adverse events.  Therefore, a minimally-supervised exercise 
program for mobile people with Parkinson’s disease who are at risk of falling might 
reduce overall risk of falling and improve muscle strength and can improve freezing and 
sit to stand speed.  The results of this study have informed the implementation of a 
larger randomised controlled trial to assess whether this relatively small reduction in fall 
risk translates into actual falls prevented. 
 
Reduced balance is a commonly experienced risk factor for falls in people with 
Parkinson’s disease. However, the effect of exercise and motor training on balance in 
people with Parkinson’s disease was unclear and had not been subjected to meta-
analysis. A systematic review with random effects meta-analysis was conducted to 
determine the effects of exercise and motor training on balance-related activity 
performance in people with Parkinson’s disease. Meta-regression was used to 
investigate if the total dose of exercise and the presence of highly-challenging balance 
training are associated with the size of the effect of intervention on balance-related 
activities. Seven electronic databases were searched in September 2009. Trials were 
included if they were published randomised controlled trials of an intervention designed 
for people with Parkinson’s disease that compared exercise and/or motor training with a 
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no intervention or placebo control group, and were evaluated with a measure of balance. 
The primary outcome measures were balance-related activity performance and falls. The 
balance-related activity performance measure involved pooling the single most 
comprehensive balance measure from each trial and included (in order of priority): the 
Berg Balance Scale, the Timed Up and Go, gait velocity/time, turning time, sit to stand 
time, Functional Reach and single leg stand time. The outcomes were included in this 
order to prioritise outcomes the author considered to be the most global measures of 
balance or balance-related activity performance. Secondary outcome measures included 
these individual balance measures as discrete measures as well as step/stride length and 
cadence. The balance-related activity performance meta-analysis included 15 trials with 
747 participants and the falls meta-analysis included 2 trials with 250 participants. The 
pooled estimate of the effect showed that exercise and motor training significantly 
improved balance-related activity performance (Hedges’ g = 0.34, 95% CI 0.11 to 0.57, 
P = 0.004) but there was no evidence of an effect on the proportion of fallers (risk ratio 
= 1.02; 95% CI 0.66 to 1.58, P = 0.94). Exercise and motor training was found to have a 
small positive effect on gait velocity and step/stride length as well as a moderate effect 
on turning time. The greatest relative effects of exercise and motor training on balance-
related activity performance tended to occur in programs with highly-challenging 
balance training (P = 0.16), but there was no evidence of an association with the total 
dose of exercise (P = 0.98). There were non-significant trends towards improvement for 
most other outcome measures. Therefore, exercise and motor training can improve the 
performance of balance-related activities in people with Parkinson’s disease. However, 
further research is required to determine if falls can be prevented using exercise 
approaches in this population. 
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While leg muscle weakness is a risk factor for falls in people with Parkinson’s disease, 
muscle strength is not commonly considered to be affected by the disease process and 
muscle weakness is usually not apparent on clinical examination. However, people with 
Parkinson’s disease often report feeling weak. One of the reasons for this discrepancy is 
the presence of bradykinesia (slowness of movement), making it difficult to ascertain if 
people with Parkinson’s disease are truly weak, or just slow to develop muscle force. 
The measurement of muscle power (force × velocity of contraction) has the potential to 
clarify the relationship between muscle weakness and bradykinesia in people with 
Parkinson’s disease. Furthermore, in the general older population, muscle power appears 
to be a better predictor of falls and physical activity performance than muscle strength. 
While modern variable resistance technology has the ability to measure muscle strength 
without the interference of bradykinesia, as well as muscle power, these measurements 
had never been reported in people with Parkinson’s disease. A descriptive study with 
two parts was conducted utilising this technology. 
 
Part one aimed to determine if the leg extensor muscles of people with mild to moderate 
Parkinson’s disease are weaker and/or less powerful than a neurologically-normal 
control group, and determine the relative contributions of force and movement velocity 
to muscle power in people with Parkinson’s disease. The leg extensor muscle strength 
(N) and power (W) of 40 participants with Parkinson’s disease and 40 neurologically-
normal participants of similar age and gender were assessed. The Parkinson’s disease 
group were 16% weaker (mean between-group difference = 172N, 95% CI 28 to 315) 
and 22% less powerful (mean between-group difference = 124 W, 95% CI 32 to 216) 
than the control group. Muscle power was disproportionately reduced at light to medium 
loads due to reduced movement speed, whereas at heavy loads this bradykinesia was no 
-xi- 
longer apparent. These results suggest that reduced muscle power at lighter loads arises 
from weakness and bradykinesia combined, but at heavier loads arises primarily from 
weakness.  
Part two aimed to examine the relationship of muscle strength/power with walking 
speed and past falls in people with Parkinson’s disease. Walking velocity over 10 m and 
the number of falls experienced in the prior 12 months was recorded for the 40 
aforementioned participants with Parkinson’s disease. Muscle power was found to 
explain more than half the variance in walking velocity (R2 = 0.54) and remained 
significantly associated with walking velocity in models which included a measure of 
Parkinson’s disease severity. Furthermore, participants with low muscle power were 6 
times more likely to report multiple falls in the prior 12 months than those with high 
muscle power (Odds Ratio = 6.0, 95% CI 1.1 to 33.3), although this association between 
falls and power was no longer significant in models which included Parkinson’s disease 
severity. However, muscle power was consistently found to explain as much or more of 
the variation in walking velocity, and was more strongly associated with past falls, than 
muscle strength. Adequate leg extensor muscle power therefore seems likely to be 
important for maximising mobility and reducing fall risk in people with Parkinson’s 
disease. A Parkinson’s disease fall risk score that includes leg muscle power instead of 
strength should be trialled, and the effect of muscle power training on walking speed 
and falls in people with Parkinson’s disease warrants investigation.  
 
Overall, the research presented in this thesis provides three pieces of evidence related to 
exercise and fall risk in people with Parkinson’s disease. Firstly, exercise interventions 
can improve freezing of gait and are likely to improve muscle weakness and balance in 
people with Parkinson’s disease. Improvements in these potentially remediable risk 
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factors for falls may lead to a reduction in the overall risk of falling in this group. 
Secondly, it appears that muscle weakness and reduced muscle power are due, in part, to 
the disease process itself.  Finally, reduced muscle power is likely to also be a risk factor 
for falls in Parkinson’s disease and may be more important to address with exercise 
interventions than muscle weakness. These results provide evidence to assist clinicians 
and researchers in devising exercise programs for people with Parkinson’s disease. Any 
reduction in falls in this group will improve the quality of life of people with 
Parkinson’s disease and their carers and help to reduce pressure on health care systems. 
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PREFACE 
This thesis consists of three studies and is arranged into six chapters. Chapter 1 is an 
introduction to the thesis and provides an overview of the relevant literature regarding 
falls and fall risk factors in Parkinson’s disease. Chapter 2 (Study 1) presents a 
randomised controlled trial with blinded assessment that evaluated an exercise program 
designed to reduce fall risk in people with Parkinson’s disease. This study is based on 
current knowledge of potentially remediable risk factors for falls in Parkinson’s disease 
and seeks to respond quickly to the pressing problem of frequent falls in people with 
Parkinson’s disease. This paper is presented as published in Movement Disorders.  
 
Chapters 3, 4 and 5 (Studies 2 and 3) seek to extend our knowledge and to inform the 
future development of falls prevention exercise programs for people with Parkinson’s 
disease. Chapter 3 is a report of a systematic review with meta-analysis that investigated 
the effect of exercise and motor training on balance-related activity performance in 
people with Parkinson’s disease. It is presented in the format required by Movement 
Disorders, where it has been submitted for peer review. A descriptive study exploring 
muscle strength and power in Parkinson’s disease is presented in Chapters 4 and 5. 
Chapter 4 is presented as published in Movement Disorders and describes the effect of 
Parkinson’s disease on leg extensor muscle strength and power. Chapter 5 is presented 
as published in Parkinsonism and Related Disorders and describes the relationships 
between leg extensor muscle strength and power with walking speed and past falls in 
people with Parkinson’s disease. Chapter 6 concludes the thesis and contains a 
discussion of clinical implications and directions for future research in the area of falls 
prevention in Parkinson’s disease. 
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Each chapter contains its own reference list. Appendices which were published as online 
supplementary material are presented at the end of the relevant chapter, and additional, 
unpublished work from the descriptive study is presented as an appendix at the end of 
Chapter 5. Other appendices are presented at the end of the thesis. Ethical approval from 
The University of Sydney Human Ethics Committee was granted prior to data collection 
for the two studies involving participants that are presented in this thesis.  
 
Chapter 1 
Introduction 
Chapter 2 (study 1) 
Randomised controlled 
trial of an exercise 
intervention to reduce fall 
risk 
2007/2008 
Chapters 4 and 5 (study 3) 
Descriptive study 
exploring muscle strength 
and power 
2007/2008 
Different groups of 
participants 
Need for urgent response to 
problem of falls in Parkinson’s 
disease 
Need to extend knowledge and 
inform future falls prevention 
initiatives  
Chapter 3 (study 2) 
Systematic review of the 
effect of exercise and 
motor training on balance 
2009 
Need to continue to extend 
knowledge and inform future 
falls prevention initiatives  
Effect of exercise and motor 
training on balance unclear  
Chapter 6 
Conclusion 
Flow chart explaining order of presentation of studies. 
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CHAPTER 1 
 
Introduction 
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OVERVIEW OF CHAPTER 1 
This chapter provides a background and rationale for the studies contained in this thesis. 
It begins with an introduction to Parkinson’s disease, outlining the pathophysiology of 
the disease, common impairments and activity limitations, as well as pharmaceutical and 
surgical management of the disease. Falls and fall risk in people with Parkinson’s 
disease are then addressed, including the prevalence and impact of falls, exercise for 
falls, fall risk, risk factors for falls and exercise for potentially-remediable risk factors 
for falls. Specific impairments which have not traditionally been considered to be major 
motor impairments or risk factors for falls in Parkinson’s disease, specifically muscle 
strength and power, are then addressed. The Chapter concludes by presenting the 
detailed aims of the thesis in evaluating and exploring interventions with the potential to 
reduce fall risk in people with Parkinson’s disease. 
 
INTRODUCTION TO PARKINSON’S DISEASE 
Pathophysiology 
Parkinson’s disease is a chronic, progressive, neurodegenerative disease for which there 
is no known cure.  It is the second most common neurodegenerative disease, exceeded 
only by dementia.1, 2 The most common age of onset is after 50, though it can affect 
younger individuals.3  While in a small number of cases Parkinson’s disease is genetic, 
in most cases the cause of Parkinson’s disease is unknown.1, 2   
 
Traditionally, Parkinson’s disease was believed to result from a pathological process 
beginning in the substantia nigra of the basal ganglia.  However, recent work provides 
evidence that degeneration begins in the dorsal motor nucleus of the vagal nerve and 
olfactory nucleus, followed by the lower brain stem, then the basal ganglia and forebrain 
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and finally extending into the cortex.4, 5  The loss of dopaminergic neurones from the 
substantia nigra is thought to be responsible for many of the motor symptoms of 
Parkinson’s disease, with the disease becoming apparent when around 80 percent of the 
nerve cells in the substantia nigra have degenerated.6  However, some impairments (both 
motor and non-motor) respond poorly to dopaminergic medications and are thought to 
be due to degeneration of other parts of the brain.7  
 
Impairments and activity limitations 
The World Health Organization’s International Classification of Functioning, Disability 
and Health (ICF)8 provides a useful model for understanding the symptoms and impact 
of Parkinson’s disease. In this model, functioning and disability are both umbrella terms, 
where functioning encompasses all body functions, activities and participation while 
disability encompasses impairments, activity limitations and participation restrictions. 
The ICF consists of two parts, each with two components.  
 Part 1. Functioning and Disability 
a) Body Functions and Structures 
b) Activities and Participation 
Part 2. Contextual Factors 
c) Environmental Factors 
d) Personal Factors 
World Health Organization (2001), p 108 
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Under this framework, impairments are “…problems in body function or structure such 
as a significant deviation or loss” and activity limitations are “…difficulties an 
individual may have in executing activities.” (World Health Organization (2001), p 10)8.  
These ICF concepts will be used throughout this thesis.  
 
Parkinson’s disease has traditionally been characterised by four cardinal features – 
bradykinesia (slowness of movement), rigidity, tremor and postural instability (ie 
reduced balance not caused by primary visual, vestibular, cerebellar or proprioceptive 
dysfunction).9  Additionally, freezing is considered to be a classic feature of Parkinson’s 
disease.10  For a diagnosis of Parkinson’s disease to be made there must be a presence of 
bradykinesia and at least one of the other cardinal features.  A good response to 
levodopa medication further confirms the diagnosis.9   
 
The term bradykinesia means slowness of movement, but is often used synonymously 
with akinesia (lack of movement) and hypokinesia (reduced amplitude of movement).  It 
affects all motor activities and is responsible for the slow, shuffling gait, absence of arm 
swing and lack of facial expression typical of the person with Parkinson’s disease.11-13  
Bradykinesia appears to primarily be caused by failure of the basal ganglia to adequately 
support cortical mechanisms preparing for and executing movement, resulting in slowed 
development of muscle force when initiating movement.14  
 
The rigidity present in Parkinson’s disease causes the individual to feel tightness and 
stiffness in their joints and muscles, and can contribute to discomfort and pain.  There is 
an increased resistance to passive joint movement in both the extensor and flexor 
muscles which is present even during slow velocity stretch,15 though it does have a 
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velocity-dependent component.16  Rigidity may be accompanied by the cogwheel 
phenomenon (a regular interruption at a 5 to 6 Hz frequency), likely due to underlying 
tremor.10   
 
The tremor associated with Parkinson’s disease is a resting tremor of about 4 to 6 Hz.  It 
usually diminishes or ceases during intended movements,17 is exacerbated by emotional 
stress and is absent while the individual is asleep.18  Tremor typically affects the hands, 
feet, lips, chin and jaw.10  Postural tremor (tremor while voluntarily maintaining a 
position against gravity) and/or action tremor can also be present and tends to be more 
prominent and disabling than resting temor.10  
 
Balance (or postural stability) is a “generic term to describe the dynamics of body 
posture to prevent falling” (Winter 1995, p 3).19 Balance requires maintenance of the 
body’s centre of mass within the limits of the base of support while sitting or standing, 
or control of it while moving to a new base of support while walking or running.19  
Postural adjustments are task and context specific muscle activations used to maintain 
balance.20  Postural adjustments can be broadly categorised into two groups: 
anticipatory and ongoing postural adjustments, and reactive postural adjustments.  
Anticipatory and ongoing postural adjustments occur immediately prior to and during a 
volitional movement, as an integral part of that movement.21  Reactive postural 
adjustments occur in response to an external perturbation, such as being pushed or 
bumped.21  
Most people with Parkinson’s disease will develop reduced balance at some stage,22 and 
balance problems tend to worsen with increased disease severity.23, 24  Balance is often 
tested clinically using the postural stability item of the Unified Parkinson’s Disease 
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Rating Scale (UPDRS),25 where the individual is rapidly pulled backwards at the 
shoulders.  Those with poor balance reactions either do not respond and must be caught 
by the assessor, or take an abnormally large number of backward steps to recover.  
Balance is also required for reaching and other tasks where the individual must control 
movements of their body to achieve a task without falling.26  While reduced balance is 
considered to be a motor impairment on its own, other problems including bradykinesia, 
rigidity, dyskinesia, shuffling gait, narrowed base of support, stooped posture and 
cognitive impairment can all compound the balance problem and impede task 
performance.27  Individuals with poor balance are more likely to fall, have poor 
mobility, difficulty performing daily activities and reduced quality of life.27, 28  A more 
detailed review of balance in Parkinson’s disease can be found in Appendix 1. 
 
Freezing refers to difficulty starting or continuing movement and is a disabling and 
frustrating problem experienced by many people with Parkinson’s disease.10, 29  Freezing 
most commonly affects gait, however it can also interfere with other tasks such as 
writing and speaking.29  Freezing of gait has recently been defined as: 
“…an episodic inability (lasting seconds) to generate effective stepping in the 
absence of any known cause other than parkinsonism or high-level gait 
disorders. It is most commonly experienced during turning and step initiation but 
also when faced with spatial constraint, stress, and distraction. Focused 
attention and external stimuli (cues) can overcome the episode.” 
      Giladi and Nieuwboer (2008), p S42430 
 
Freezing of gait is a complex phenomenon which is estimated to affect around 7% of 
people with early and 60% of people with advanced disease.31-34  It is considered to be a 
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common cause of falls in people with Parkinson’s disease as it tends to occur abruptly, 
resulting in the feet staying in the one spot while momentum carries the body 
forwards.24, 29, 33, 35  A more detailed review of freezing of gait can be found in Appendix 
2. 
 
Dyskinesia is a common motor side-effect of the dopamine replacement medications 
(levodopa and dopamine agonists) generally used to treat Parkinson’s disease.36, 37  
Dyskinesias are involuntary, purposeless movements, often writhing in nature. 
Dyskinesias usually coincide with the peak dose of medication, but can occur at the 
beginning of the medication effect and again when the medication is wearing off.36, 37  
When medication is not effective, dyskinesia can also manifest as prolonged muscle 
spasms and persistent postures of the body, also known as dystonia.36, 37  The incidence 
of dyskinesia increases with the number of years of treatment with levodopa, and occurs 
in around 90% of people treated for more than 10 years.36  While for many people 
dyskinesia is mild and non-disabling, it can become severe and painful36 and is likely to 
contribute to falls.38-40  
 
There are a wide range of non-motor impairments also associated with Parkinson’s 
disease.  These include cognitive and emotional impairments, autonomic dysfunction, 
sleep disorders and sensory abnormalities.10, 41  Cognitive impairment affects around 
25% of people with newly diagnosed Parkinson’s disease, with impairments most 
prominent in attention/executive function and memory.42  Around 30% of people will go 
on to develop Parkinson’s disease with dementia.43  Neuropsychiatric symptoms such as 
depression, anxiety, apathy and psychosis will affect most people with Parkinson’s 
disease at some stage during the course of their disease44 and can be as debilitating as 
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the motor symptoms.10  Fatigue is also a common and troubling symptom of Parkinson’s 
disease and can occur independently of depression and sleep disorders.45  
 
While the impairments and activity limitations of Parkinson’s disease are often 
described individually, they frequently influence and exacerbate each other.27  For 
example, freezing of gait is not thought to be caused by bradykinesia.33  However, 
freezing of gait that is associated with a forward loss of balance is postulated to be due 
to difficulty linking postural adjustments with stepping.46  In turn, bradykinesia is 
believed to be responsible for the slow and small postural adjustments found in people 
with Parkinson’s disease.46-51  It therefore appears that bradykinesia may exacerbate 
freezing of gait indirectly by interfering with postural adjustments. 
 
The individual experience of Parkinson’s disease is variable, with people experiencing 
the motor and non-motor impairments in various combinations and to differing extents. 
However, many of the impairments of Parkinson’s disease can predispose the individual 
to falls. For this reason, the reduction of fall risk in people with Parkinson’s disease 
presents a complex and unique challenge. 
 
Pharmaceutical and surgical management 
The mainstay of medical management for Parkinson’s disease since the 1960s is 
levodopa medication, which works to restore dopamine levels in the brain.2, 18  Many 
motor symptoms, including bradykinesia, tremor and rigidity, respond well to levodopa 
for the first five to seven years of treatment.2, 52  However, as the disease progresses, 
motor fluctuations (observed as vacillation between periods of being ON, being ON 
with levodopa-induced dyskinesia and being OFF) occur.2, 53  ON periods denote the 
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time when the Parkinson’s medication is working well and movement is free and easy 
without excessive slowness, rigidity or tremor. In contrast, during an OFF period, 
medication effects have worn off and the benefits on movement, slowness, rigidity and 
tremor are no longer present. These shortcomings of levodopa therapy have led to the 
development of many other medications aimed at prolonging the effects of levodopa, 
reducing dyskinesias and ending sudden, unpredictable OFF periods.2, 53  The 
pharmaceutical management of Parkinson’s disease is therefore complex and requires 
careful tailoring for each individual.   
 
Despite advances in the pharmaceutical management of Parkinson’s disease, 
medications used to treat Parkinson’s disease do not appear to prevent people with 
Parkinson’s disease falling.54, 55  This is largely because some motor impairments, 
including postural instability and freezing of gait, respond poorly to levodopa.2, 54, 56, 57  
Furthermore, as medication improves mobility without improving postural instability 
and freezing of gait, it may render some individuals with Parkinson’s disease at an 
increased risk of falling.27 
 
In recent years surgery in the form of deep brain stimulation of the subthalamic nucleus 
or the globus pallidus internus has increasingly been employed to manage symptoms in 
carefully selected people with more advanced disease.52, 53  Deep brain stimulation is 
effective in treating the symptoms that respond well to levodopa, such as bradykinesia, 
tremor and rigidity,52 as well as improving motor fluctuations by reducing OFF time and 
dyskinesias.58  For this reason, people with a history of a good response to levodopa, 
whose disability is largely due to motor complications and who have good cognition 
make the best candidates for deep brain stimulation.53  However, motor impairments that 
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respond poorly to levodopa, including postural instability and freezing of gait when ON, 
also tend to respond poorly to deep brain stimulation.52, 59-61  This result suggests that 
falls similarly may not be reduced by subthalamic or globus pallidus internus 
stimulation, and some authors suggest that individuals experiencing frequent falls due to 
postural instability should be excluded from deep brain stimulation surgery.52  Non-
pharmacological and non-surgical interventions, such as exercise, may therefore, hold 
the key to falls reduction in people with Parkinson’s disease.  
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FALLS AND FALL RISK IN PARKINSON’S DISEASE 
Prevalence of falls 
People with Parkinson’s disease fall frequently and recurrently.  They are twice as likely 
to fall as people with other neurological conditions, and are nine times more likely to 
experience recurrent falls than healthy individuals of the same age.38, 62  A meta-analysis 
of six prospective studies of falling in Parkinson’s disease63 found that 46% of 
participants fell in a 3 month period.  Of the participants who had not fallen in the 
previous 12 months, 21% fell in the 3 month follow-up period.  In one of these studies 
with a 12 month follow-up, over two thirds of participants fell, with half falling more 
than once.64  Further, in a survey of 100 people with Parkinson’s disease, 13% reported 
falling more than once a week.55  Given that there were at least 54,700 Australians with 
Parkinson’s disease in 2005,1 there are likely to be over 800,000 falls each year due to 
Parkinson’s disease in Australia alone.  Furthermore, it is estimated that from 2005 to 
2030 the prevalence of Parkinson’s disease in developed countries will almost double.65  
Therefore, the incidence of Parkinson’s disease-related falls can be expected to have an 
even bigger impact on health care systems around the world in the coming decades. 
 
Impact of falls 
The consequences of people with Parkinson’s disease falling are significant and far-
reaching, affecting the person with Parkinson’s disease, their family and the community.  
Falls frequently result in injury, causing pain and requiring costly medical intervention.  
They also contribute to increased fear of falling, reduced activity levels, poor quality of 
life and caregiver stress.   
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People with Parkinson’s disease regularly injure themselves when they fall. While most 
of these injuries are soft tissue damage, more serious injuries are common, with 
fractures occurring more frequently in people with Parkinson’s disease than in healthy 
individuals of the same age.38, 66-69  Overall, the relative risk of fracture is doubled in 
those with Parkinson’s disease, with the greatest increase in risk being for hip 
fracture.66, 67  This increased risk for hip fracture is thought to be due to abnormally 
directed arm movements in response to loss of balance.  People with Parkinson’s disease 
have been found to adduct their arms against their body instead of using their arms to 
reach for support or to break their fall.54, 70  Consequently, the person with Parkinson’s 
disease has an increased chance of landing on, and so possibly fracturing, his/her hip. 
 
The financial cost of falls amongst people with Parkinson’s disease is high.  Falls and 
related fractures are a common reason for hospital admission in Australia.  A study of 
761 hospital admissions for people with Parkinson’s disease71 found that only 15% of 
these were primarily for management of the patient’s Parkinson’s disease.  Of the 
remaining admissions, falls and related fractures were the most frequent cause for 
admission, accounting for almost 13% of admissions.  Furthermore, the treatment of 
fractures in people with Parkinson’s disease poses a significant economic burden on the 
individual and the health care system.  The costs associated with treating fractures in 
people with Parkinson’s disease are close to double, and for treating a fractured hip are 
close to triple the costs for treating fractures in healthy older people.67   
 
Frequent and injurious falls often lead to fear of falling, which is a widespread problem 
for people with Parkinson’s disease.  While some individuals at a high risk of falls are 
not fearful of falling, community-dwelling people with Parkinson’s disease overall have 
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a greater fear of falling than healthy individuals of the same age.38, 72  A 6 month 
prospective study of ambulant community residents found 46% of people with 
Parkinson’s disease were fearful of falling, compared to 7% of healthy people of the 
same age.  Furthermore, falls were more likely to lead to an increased fear of future falls 
in the Parkinson’s disease group.38 
 
Fear of falling reduces people’s activity levels and quality of life.  While cautious 
behaviour and avoidance of hazardous activities can help to lower the individual’s risk 
of falling, too much restriction of activities can lead to decline in function and mobility, 
social isolation and poor quality of life.28, 38  In the afore-mentioned prospective study of 
people with Parkinson’s disease, 96% of people who reported fear of falling also 
reported restricting their physical activity levels.38  This is likely to contribute to the 
substantial correlation (R2 = 0.74) between reduced quality of life and higher fear of 
falling found amongst people with Parkinson’s disease.28   
 
Carers of recurrent fallers with Parkinson’s disease report high levels of stress caused by 
fear of the person falling.  A postal survey of 116 caregivers found that those caring for 
a person with Parkinson’s disease who had fallen, had poorer quality of life and higher 
levels of caregiver burden than carers of people who had not fallen.73  A study of carers 
of recurrent fallers with Parkinson’s disease74 found that carers experienced high 
demands on their physical, psychological and social wellbeing.  The carers often injured 
themselves trying to help the person with Parkinson’s disease up from the floor, were 
fearful of leaving the person unattended and felt unable to leave the house.   
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Falls are clearly a major problem for people with Parkinson’s disease, their carers and 
healthcare systems. As falls do not appear to be prevented by Parkinson’s disease 
medication or surgery,52, 54, 55 there is a pressing need to evaluate and explore exercise 
interventions with the potential to reduce falls in people with Parkinson’s disease.  
 
Exercise for falls 
A substantial amount of research has explored the effects of exercise on falls in the 
general older population.75, 76    Meta-analyses have consistently shown that exercise can 
prevent falls in this group,75, 76 resulting in an estimated 17% reduction in fall rates.76  In 
particular, exercise programs combining 2 or more types of exercise into either an 
individually prescribed home-based program or a group program have been shown to be 
effective.75, 77-81  Many different types of exercise have been explored, including 
balance, strength, cardiovascular and flexibility exercises. While all of these types of 
exercise have the potential to provide beneficial health outcomes, specificity of training 
means that these beneficial effects will vary depending on the type of exercise 
completed.  For falls prevention, programs which combine a higher total dose of 
exercise (> 50 hours over trial period) with exercises that challenge balance have been 
shown to be the most effective in reducing falls rates.76  Importantly, this research is 
informing the implementation of successful falls prevention exercise programs for the 
general older population throughout the developed world. 
 
While it is clear that exercise can reduce falls in the general older population, there is no 
such evidence regarding falls in people with Parkinson’s disease.  Only three published 
randomised controlled trials to date have reported the effect of exercise on falls in 
people with Parkinson’s disease.82-84  The first trial82 found no effect on falls from a 
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fully-supervised eight week program of treadmill walking and training steps in response 
to perturbations on a treadmill.  However, the trial was too small (n = 18) to be able to 
detect an effect on falls if one had existed.   
 
The second trial83 investigated the effect of a three week home-based program of 
rhythmical cueing of gait and gait-related activity. There was no effect on fall rates, 
however the trial did not target fallers and did not aim to reduce falls.  Rather, fall rates 
were measured to check that the intervention group participants’ increased activity was 
not leading to an increase in falls.  However, results did show increased confidence for 
not falling, along with improved balance and gait as well as reduced freezing in 
participants for whom freezing was a problem. 
 
The third trial84 did target fallers with Parkinson’s disease and showed promising 
results.  This six week home-based program incorporated a broad range of exercises 
including strengthening, range of movement, balance and walking exercises as well as 
strategies to reduce falls and improve movement and movement initiation. Results 
showed a trend towards a reduction in fall events (unadjusted difference between 
exercise and control groups =  -9% (95% CI = -25% to 8%)) and a significant reduction 
in near-falls (unadjusted difference between exercise and control groups = -15% (95% 
CI = -30% to -1%)).  Notably, all three trials82-84 involved a relatively short duration of 
intervention and are well short of the total dose of exercise (> 50 hours) found to be 
more effective in reducing falls in the general older population.76  It is likely that people 
with Parkinson’s disease would also receive greater benefits from higher-dose programs 
involving several months of exercise. 
 
-16- 
Fall risk 
Ideally, studies of falls prevention interventions use fall rates as the primary outcome 
measure.  However, studies with falls outcomes require a large sample size, which can 
be difficult to achieve in people with specific health problems, such as Parkinson’s 
disease.  As an alternative, some studies of older people have used a fall risk score as the 
primary outcome measure to give an indication of the likely effects on falls 
themselves.85, 86  In order to develop effective exercise programs for reduction of fall 
risk in people with Parkinson’s disease, it is first important to identify and understand 
potentially modifiable risk factors for falls. 
 
Risk factors for falls 
Risk factors for falls in the general older population include impaired gait, reduced 
balance, lower limb weakness, polypharmacy, foot problems, peripheral sensory deficits 
and visual and hearing deficits.40, 87-90  As Parkinson’s disease tends to affect people 
over 50 years of age, these risk factors will also apply to many people with Parkinson’s 
disease. However, the impairments associated with Parkinson’s disease mean that there 
are also disease-specific risk factors in this population.40  
 
The identification of risk factors for falls in Parkinson’s disease has received increasing 
attention in recent years38-40, 64, 91-95 and many different risk factors have been proposed. 
A meta-analysis of six prospective studies of falling in Parkinson’s disease63 reported 
that the best predictor of falling was two or more falls in the previous year. However, 
participants without a history of falls still had a 21% risk of future falls. This result 
highlights the importance of identifying fall risk factors that are potentially remediable 
and detectable before the first fall. 
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Several studies have reported that lower limb muscle weakness (ie a deficit in maximal 
force production), freezing of gait and reduced balance are risk factors for falls in 
Parkinson’s disease.39, 40, 93, 94  In particular, a prospective study of risk factors for falls 
in 113 people with Parkinson’s disease94 found that these three factors were independent 
risk factors for falls, regardless of whether previous falls had occurred or not. Lower 
limb muscle weakness, freezing of gait and reduced balance are all potentially 
remediable with exercise and able to be detected before the onset of falls. It is therefore 
logical to target these three risk factors for falls with exercise. Furthermore, an 
algorithm to calculate fall risk using measures of these three risk factors has been 
developed.94  Therefore, the randomised controlled trial presented in Chapter 2 of this 
thesis investigates the effect on fall risk of a sustainable, six-month exercise program for 
people with Parkinson’s disease which targets these three risk factors and applies this 
fall risk score. 
 
Exercise for potentially-remediable fall risk factors 
Muscle weakness 
High intensity resistance training improves muscle strength and the functional abilities 
of people with Parkinson’s disease.96-101  People with mild to moderate Parkinson’s 
disease have been reported to achieve similar increases in muscle strength as 
neurologically-normal people of the same age after progressive resistance training.96, 98  
In addition, increases in muscle strength were accompanied by improved gait velocity,98, 
101 stride length,98 Timed Up and Go time,101 6 minute walk test distance96 and stair 
descent time.96  Moreover, resistance training combined with balance training has been 
shown to result in greater improvements in balance in people with Parkinson’s disease 
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than balance training alone.97  These results suggest that muscle strength training may 
play an important role in falls prevention in people with Parkinson’s disease, and 
requires further investigation.   
 
To date, published studies examining the effect of resistance training in people with 
Parkinson’s disease have utilised specialised strength training equipment, requiring 
participants to attend and be supervised at a gym facility or clinic to use them.96-101  
However, simpler, cheaper methods of applying resistance, such as weighted vests or 
belts, have been used successfully in older people102-104 and in people with multiple 
sclerosis.105  The randomised controlled trial presented in Chapter 2 evaluated these 
pragmatic, readily accessible methods for applying resistance in people with Parkinson’s 
disease. 
 
Freezing of gait 
The main intervention used to address freezing of gait is cueing.  Cueing refers to the 
use of external temporal or spatial stimuli to assist the initiation and continuation of 
walking.83  Cueing is known to engender immediate improvements in gait speed and 
step length in people with Parkinson’s disease.106, 107  It is also known that freezing of 
gait episodes can quickly be overcome with cues.  However, most research has looked at 
the effect of a single intervention session,108-113 so the longer term, therapeutic effect of 
cueing on freezing of gait is less clear.114  
 
Freezing of gait episodes often occur during gait initiation and when turning during 
walking.115 A few small descriptive studies have assessed the effect of cueing in these 
situations.47, 111-113  Overall, these studies suggest that visual cues may be of most benefit 
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during gait initiation as they encourage an increase in step size, and that auditory cues 
may be of most benefit when turning as they reduce asymmetry and help to maintain 
timing.114  However, there is currently no evidence that these improvements will reduce 
freezing during gait initiation or turning. 
 
Nieuwboer et al83 is the only large, high quality randomised controlled trial to address 
the effect of cueing intervention on freezing of gait in people with Parkinson’s disease. 
In this trial 153 participants, 63 of whom experienced freezing, undertook 9 sessions 
over 3 weeks of training in the use of auditory (beeps through an ear-piece) or 
somatosensory (vibrations to the wrist) cues. Cueing training was incorporated into 
functional situations at the participant’s home and participants who experienced freezing 
practised using the cue in circumstances that tended to provoke their freezing. Results 
did not show an overall effect on freezing. Nonetheless, the sub-group who did 
experience freezing problems reported a 1.3 point mean between-group difference in the 
Freezing of Gait Questionnaire (P = 0.007, scale from 0 to 24) at post-test, suggesting 
that cueing training can improve freezing of gait in those for whom freezing is a 
problem. This study was therefore used as a model for the delivery of cueing training to 
participants for whom freezing was a problem in the randomised controlled trial 
presented in Chapter 2. 
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Reduced balance 
Balance is an inherent part of most daily activities and so can be observed during the 
performance of those activities. Balance can be assessed with tasks specifically designed 
to make controlling the centre of mass over the base of support difficult (eg, coordinated 
stability test).116  However, many daily activities, such as reaching or turning around, 
also require control of the centre of mass over the base of support and are challenging 
for people with balance impairment. Therefore balance can also be assessed clinically by 
measuring the performance of these balance-demanding activities.  
 
Balance is able to be improved in the general older population,76, 117 and is considered to 
be potentially remediable in people with Parkinson’s disease.40, 94  However, the effect 
of exercise on balance in people with Parkinson’s disease is unclear.  Randomised trials 
to date have used a diverse range of intervention strategies and outcome measures.82-84, 
97, 118-123  While some studies have reported promising results,82, 97, 119-121, 123  many of 
these studies are small and/or of poor methodological quality.   
 
There does not appear to be a single intervention type or measure that consistently 
shows improvement in people with Parkinson’s disease and several high quality studies 
have measured a number of balance outcomes, but have found improvement in only one 
or two.83, 84, 118  Ashburn et al84 conducted a randomised controlled trial of a six week 
home-based program for fallers with Parkinson’s disease, which incorporated strength, 
range of movement, balance and walking exercises as well as strategies to improve 
movement and reduce falls. Results showed no statistically significant effect on the Berg 
Balance Scale, the Timed Up and Go, the chair stand test or the Functional Reach test. 
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Nieuwboer at al83 reported a randomised cross-over trial of a three week home-based 
program of rhythmical cueing, aimed at improving step length, walking speed and 
balance and reducing freezing of gait. Results did not show any effect on Functional 
Reach or Timed Up and Go.  The single leg and tandem stand times also did not 
improve, though there was a significantly reduced chance of failing (not reaching 30s) 
in these tests after intervention.  There was significant improvement in a Posture and 
Gait score (UPDRS25 items 13-15 (falling, freezing when walking, walking) and 29-30 
(gait, postural stability) after intervention. However, improvements were temporary with 
the effects of intervention declining by the 6 week follow-up.   
 
Morris et al118 conducted a randomised controlled trial comparing the effects of two 
weeks of movement strategy training with exercise in hospitalised people with 
Parkinson’s disease.  The movement strategy training involved using cognitive 
strategies including focused attention and external cues when performing tasks such as 
walking, turning, standing up from a chair and negotiating obstacles. The exercise 
program included conventional exercises aimed at improving strength, range of 
movement, posture, general fitness and ability to perform everyday activities. A battery 
of previously published balance tests124 was conducted. This battery includes the 
balance pull test, tandem stand time, single leg stand time and Functional Reach. The 
only reported difference between the groups was in the balance pull test (response to an 
unexpected backwards perturbation) which improved in the movement strategy group, 
but did not improve in the exercise group.  The between-group difference in the balance 
pull test was diminished by the 3-month follow-up. Furthermore, neither group showed 
improvement in the Timed Up and Go test. 
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There is, therefore, no consensus as to the most effective form of exercise to address 
balance impairment in people with Parkinson’s disease. In the general older population, 
highly-challenging balance exercises, characterised by movement of the centre of mass, 
narrowing of the base of support and minimization of upper limb support, have been 
shown to be the most effective.76  The balance training provided in the randomised 
controlled trial presented in Chapter 2 was therefore based on these principles. 
 
Despite the lack of clarity regarding the effect of exercise on balance in Parkinson’s 
disease, there has only been one systematic review to specifically address this issue.125  
Dibble et al125 concluded that there was moderate evidence that exercise improved 
balance and the performance of balance-demanding activities, and limited evidence that 
exercise reduced falls. This review, however, did not include any meta-analysis. 
Furthermore, of systematic reviews exploring the effectiveness of exercise for people 
with Parkinson’s disease,106, 107, 114, 125-137 only two published papers136, 137 have included 
any meta-analysis, and to date no reviews have reported a meta-analysis of balance 
outcome measures. Chapter 3 presents the first systematic review with meta-analyses to 
assess the effects of exercise on balance-related activity performance in people with 
Parkinson’s disease. 
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Summary of falls and fall risk in Parkinson’s disease 
Falls are a major problem for people with Parkinson’s disease and do not appear to be 
prevented with modern medical management. There is a paucity of research examining 
the effects of exercise training on falls in people with Parkinson’s disease and such 
research requires large sample sizes in order to achieve the statistical power required to 
detect an effect on falls. Furthermore, trials to date have involved a relatively short 
duration of intervention which may not be sufficient to improve fall rates. Despite this, 
some promising results have been reported. The use of a fall risk score offers an 
alternative outcome measure capable of providing an indication of the likely effects on 
falls. Muscle weakness, freezing of gait and reduced balance are fall risk factors in 
Parkinson’s disease which are potentially remediable with exercise and for which a fall 
risk score algorithm has been developed. The randomised controlled trial presented in 
Chapter 2 used this algorithm to assess the effect on fall risk of a sustainable, 6 month-
exercise program which targeted muscle strength, freezing of gait and balance. 
 
While balance is often considered to be potentially remediable in people with 
Parkinson’s disease, published research revealed the effect of exercise on balance in 
people with Parkinson’s disease is unclear. The systematic review with meta-analysis 
presented in Chapter 3 clarifies the effects of exercise on balance-related activity 
performance in people with Parkinson’s disease. 
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MUSCLE STRENGTH AND POWER IN PARKINSON’S DISEASE 
Muscle strength 
Progressive loss of muscle strength with increasing age is widely acknowledged.  A 
longitudinal study138 of the lower limb muscle strength of men and women (initially 
aged 46 to 78 years) reported an average 14% decline in knee extensor strength and an 
average 16% decline in knee flexor strength over 10 years.  This reduction in muscle 
strength is accompanied by a reduction in muscle mass, both of which are believed to be 
mainly due to a loss of muscle fibres with age.139   
 
It is unclear whether or not Parkinson’s disease leads to muscle weakness over and 
above that caused by ageing.  Although people with Parkinson’s disease often report 
feeling weak,140 this weakness is usually not apparent during clinical examination.141, 142  
Furthermore, attempts to quantify muscle strength in people with Parkinson’s disease 
have yielded mixed results, and it remains uncertain as to whether people with 
Parkinson’s disease are weaker than neurologically-normal people of the same age. 
 
Measurement of muscle strength 
The uncertainty surrounding muscle weakness in Parkinson’s disease is partly due to 
bradykinesia. It can be argued that what appears to be muscle weakness is actually a 
slowness to develop muscle force. It is thought that bradykinesia results from inadequate 
generation of muscle force when initiating movement, caused by failure of the basal 
ganglia to adequately support cortical mechanisms preparing for and executing 
movement.14  The abnormal force generation patterns seen in people with Parkinson’s 
disease support this hypothesis.  Electromyographic studies of rapid arm movements in 
people with Parkinson’s disease have found a reduced rate of rise of agonist 
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electromyographic activity, as well as an increased number of agonist bursts and an 
increase in agonist/antagonist co-contraction.143-147  Furthermore, there is a reduced rate 
of force production and release during isometric muscle contractions.144, 148-150  These 
abnormalities in force generation patterns appear to be an underlying component of 
bradykinesia.  However, they also have the potential to influence the results of muscle 
strength testing.   
 
Isokinetic strength testing involves movement at a constant predetermined velocity, so it 
is likely to be influenced by bradykinesia.142  Studies of isokinetic strength have 
consistently reported muscle weakness in Parkinson’s disease compared to healthy 
control groups.141, 151, 152  The fact that muscle strength – when measured isokinetically – 
deteriorates as the speed of muscle contraction increases,153, 154 is evidence of the 
influence of bradykinesia on this type of measurement. 
 
Isometric muscle strength testing has been described as a more “pure” form of strength 
testing as it does not involve movement.142  Provided the individual with Parkinson’s 
disease is given adequate time to generate force, isometric muscle testing will give a 
more accurate picture of the maximum force the individual is able to produce.  Studies 
comparing the isometric muscle strength of people with Parkinson’s disease before and 
after taking antiparkinsonian medication have found muscle strength is improved after 
medication.146, 150, 155  However, studies of isometric muscle strength in people with 
Parkinson’s disease compared to a neurologically-normal control group, have yielded 
variable results.  Some studies have reported no difference in strength,141, 142, 144, 156, 157 
while others found that weakness was present in the Parkinson’s disease group.146, 158, 159   
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Until recently it has been difficult to measure muscle strength in a way that is both 
accurate and functionally relevant.  Measures of muscle strength taken on the basis of 
the weight a person can lift do not provide an accurate measure of the force they are 
exerting.  Since force = mass x acceleration, when a weight is lifted, the force required 
changes with even small changes in acceleration.  In order to measure muscle force in a 
way that is reproducible and accurate, traditional measures have sought to control 
movement speed, resulting in the use of isokinetic and isometric techniques.  
Unfortunately, however, these techniques are not functionally relevant as they do not 
provide strength measures which reflect the way human muscles are predominantly used 
for most everyday activities.  As a consequence, the relevance of isokinetic and 
isometric muscle strength testing is unclear.   
 
Recent advances in technology have led to the development of a pneumatic variable 
resistance machine (Keiser Sports Health Equipment, Fresno CA).  As the machine is 
able to vary the resistance, it allows muscle strength to be measured while the 
participant lifts the load at his/her own speed.  In this way it provides an accurate and 
reproducible muscle strength measure160 that reflects the individual’s ability to use their 
muscles in a functional way.  Furthermore, this technique can allow for the fact that 
when lifting very heavy loads at the limits of their strength, all people will lift slowly, 
regardless of whether they have Parkinson’s disease or not.  This form of measurement 
should, therefore, be useful for measuring muscle strength without the interference of 
bradykinesia in people with Parkinson’s disease.  This variable resistance technology 
has been used for testing the muscle strength of older people.160-163  Chapter 4 presents 
the results of the first published study to use this technology to measure the leg extensor 
muscle strength of people with Parkinson’s disease. 
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Impact of muscle weakness on physical activity performance and falls 
Despite the limitations of traditional measures of strength measures, when muscle 
weakness has been present in people with Parkinson’s disease, it has been shown to 
have a detrimental effect on their ability to perform physical activities.  A descriptive 
study152 of 30 people with Parkinson’s disease and 30 age- and gender-matched healthy 
controls found that people with Parkinson’s disease were weaker than the healthy group 
in their trunk, hip and ankle flexor and extensor muscles. This weakness was related to 
reduced walking speed in the Parkinson’s disease group, whereas no relationship was 
found between strength and walking speed in the healthy group.  Muscle weakness in 
Parkinson’s disease has also been reported to affect ability to stand up from a chair.  A 
study of elderly women with mild to moderate Parkinson’s disease158 found that the 
women took longer to stand up than a healthy control group and that performance was 
slowest in women with Parkinson’s disease who also had weak extensor leg muscles.  A 
similar small study of men with mild Parkinson’s disease151 also reported increased time 
to stand up and overall hip and knee extensor muscle weakness when the men had not 
taken their Parkinson’s disease medication.  Additionally, slowness to complete the 
Timed Up and Go test has been reported to be associated with leg extensor muscle 
weakness in people with Parkinson’s disease.164  These studies suggest that reduced leg 
muscle strength may contribute to reduced walking speed and difficulty standing up 
from a chair – both problems that commonly affect people with Parkinson’s disease and 
potentially could result in a situation where the individual is at risk of falling.  
 
Leg muscle weakness has in fact been found to be predictive of falls in people with 
Parkinson’s disease.94  In a 12 month prospective study of 112 people with Parkinson’s 
disease, participants who fell were found to have weaker knee and ankle muscles than 
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those who did not fall. Furthermore, reduced knee extensor muscle strength was found 
to be an independent predictor of falls. The authors94 suggested that leg extensor muscle 
strength was particularly important in falls prevention in order to prevent collapse of the 
supporting leg165 and to facilitate balance control.166, 167  The study presented in Chapter 
5 further explores the associations between leg extensor muscle strength and walking 
speed and past falls in people with Parkinson’s disease. 
 
Muscle power 
Muscle power quantifies the ability to use muscles quickly, and can be defined as force 
x speed of muscle contraction.  Adequate muscle power is required for many daily 
activities, such as standing up from a chair, walking and reacting quickly in order to 
prevent a fall.  While muscle power is related to muscle strength, measures of muscle 
power incorporate the speed at which force is applied and so are likely to provide a 
better picture of the individual’s ability to use their muscles in everyday life.168  Muscle 
power is able to be measured in a reliable and valid way160, 169 using the same pneumatic 
variable resistance equipment (Keiser Sports Health Equipment, Fresno CA) that can be 
used to measure muscle strength. 
 
Impact of reduced muscle power on physical activity performance and falls 
Beyond the fifth decade of life, muscle power is lost at a faster rate than strength (3% to 
4% vs 1% to 2% per year).170  In both healthy and disabled older people, this loss of 
power has been found to have a greater influence on the performance of physical 
activity than loss of strength.  A study of 45 older people with mobility limitations161 
found that leg extensor power predicted physical activity performance.  Furthermore, leg 
extensor power accounted for 2 to 8% more of the variance in physical activity 
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performance than leg extensor strength.  A large study of over 800 older people, most of 
whom had mild to moderate mobility limitations, subsequently confirmed these 
results.171  Leg extensor power consistently explained more of the variance in the 
performance of physical activity than leg extensor strength, such that people with low 
power were 2 to 3 times more likely to have a mobility limitation than people with low 
strength (odds ratio for poor performance if leg power was low = 8.9, 95% CI 4.0 to 
20.1; odds ratio for poor performance if leg strength was low = 2.9, 95% CI 1.5 to 5.6).  
Similarly, a study of 100 healthy older people170 found that leg extensor power was 
more highly correlated with the ability to stand up from a chair and to ascend a tall step 
than leg extensor strength.  Muscle power, therefore appears to be a better predictor of 
the performance of physical activity than muscle strength in the general older 
population.   
 
In addition to influencing the performance of physical activities, loss of muscle power 
has been found to be related to falls.  A study of 403 healthy older women172 measured 
lower limb extensor power and collected data on falls and related injuries prospectively 
for one year.  This study found that women with lower limb extensor power asymmetry 
were 1.7 times more likely to have one injurious fall and 2.4 times more likely to have 
recurrent injurious falls compared to women without power asymmetry.  Another study 
examining lower limb muscle strength and power in 35 community-dwelling female 
fallers and non-fallers aged 65 and over found that out of seven strength measures, 
fallers were weaker in only one (concentric ankle dorsiflexion).173  Fallers, however, 
were 24% less powerful in their least powerful leg than non-fallers.  Both fallers and 
non-fallers were asymmetrical in their lower limb strength and power, however fallers 
were more asymmetric than non-fallers in power only.  Therefore reduced lower limb 
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extensor muscle power, and particularly asymmetry of extensor power, appears to be 
more predictive of falls, especially injurious falls, than traditional strength measures in 
older women. 
 
The ability to generate muscle force at a high velocity appears to be a critical factor in 
determining mobility and preventing a fall. Muscle power measurements taken with low 
resistance (and therefore fast muscle contraction) have been found to have as much or 
more influence on measures of physical activity performance than power measurements 
taken at higher resistance (and therefore slower muscle contraction).  This is despite the 
fact that the measures at higher resistance gave a higher peak power reading.  A study 
compared power generated at 40% of the one repetition maximum (1RM) (ie, low 
resistance and fast muscle contraction) with power generated at 70% of 1RM (ie, high 
resistance and slower muscle contraction) in disabled older adults.163  Absolute power 
generated at 40% of 1RM was lower overall but explained more of the variability in 
walking speed and the same amount of variability in the time taken to climb stairs and to 
stand up from a chair than power generated at 70% 1RM.  This suggests that it is not 
just the force of muscle contraction, but also the speed at which it can be generated that 
determines performance of physical activities, particularly in tasks where a lower 
percentage of maximal strength, but rapid muscle contraction is required, such as 
walking.  This may also be the case in recovering from a loss of balance to prevent a 
fall. 
 
The well established influence of extensor muscle power on physical activity 
performance and falls in older people shows a clear need for muscle power to be 
investigated in people with Parkinson’s disease.  Furthermore, as muscle power 
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incorporates speed of movement as well as the force generated, measurement of muscle 
power and analysis of its components has the potential to provide information about the 
relative contributions of weakness and bradykinesia to physical activity performance 
and falls in people with Parkinson’s disease.  Chapters 4 and 5 present the first 
published study to explore the effect of Parkinson’s disease on leg extensor muscle 
power as well as the relationships between leg extensor power and walking speed and 
falls in this population. 
 
Summary of muscle strength and power in Parkinson’s disease 
The effect of Parkinson’s disease on muscle strength (force) is difficult to assess due to 
the presence of bradykinesia. The measurement of muscle power (force × speed of 
muscle contraction) has the potential to help clarify the relationship between muscle 
strength and bradykinesia. Furthermore, in the general older population, muscle power 
appears to be a better predictor of falls and physical activity performance than muscle 
strength. The muscle power of people with Parkinson’s disease has never been reported. 
Technology now exists to measure muscle strength without interference from 
bradykinesia and to measure muscle power. The descriptive study presented in Chapters 
4 and 5 utilised this technology to clarify the effect of Parkinson’s disease on leg 
extensor muscle strength and power (Chapter 4) and to investigate associations between 
leg extensor muscle strength and power with walking speed and past falls in this 
population (Chapter 5). 
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AIMS OF THE THESIS 
The overall aim of this thesis is to evaluate and explore interventions with the potential 
to reduce fall risk in people with Parkinson’s disease. This thesis contains three studies 
conducted by the candidate and presented as four journal articles, each of which may be 
read independently. The specific aims for each study are: 
 
 Study 1: to determine if a six-month randomised controlled trial of an exercise 
program which targets potentially remediable risk factors for falls in people with 
Parkinson’s disease improves: (i) performance in measures of fall risk and (ii) 
physical abilities, fear of falling and quality of life (Chapter 2). 
 
 Study 2: to systematically review the literature to examine whether exercise and 
motor training improves balance-related activity performance in people with 
Parkinson’s disease and to determine if the total dose of exercise and the presence 
of highly-challenging balance training is associated with the magnitude of any 
improvement in balance-related activity performance (Chapter 3). 
 
 Study 3: (i) to determine if people with mild to moderate Parkinson’s disease are 
weaker and/or less powerful than a neurologically-normal control group and to 
determine the relative contributions of force and movement velocity to muscle 
power in people with Parkinson’s disease (Chapter 4) and (ii) to investigate the 
relationships between leg extensor muscle strength and power with walking speed 
and past falls in people with mild to moderate Parkinson’s disease (Chapter 5). 
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CHAPTER 2 
 
The effects of an exercise program on fall risk factors 
in people with Parkinson’s disease: A randomised 
controlled trial 
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Murray SM, Fung VSC (2010) The effects of an exercise program on fall risk factors in 
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25(9):1217-1225. 
 
A supplementary file (Intervention Details) was published online with this publication. 
It is placed as an appendix at the end of this chapter. 
The exercise program used in this study is presented in Appendix 3.  
An example of a participant exercise instruction and recording sheet is presented in 
Appendix 4. 
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Abstract  
 This systematic review with meta-analysis aimed to determine the effects of 
exercise and motor training on the performance of balance-related activities and falls in 
people with Parkinson’s disease (PD). Sixteen randomized and quasi-randomized 
controlled trials that assessed the efficacy of exercise and/or motor training against no 
intervention or placebo intervention were included. The primary outcome measures were 
balance-related activity performance (15 trials) and falls (2 trials). The pooled estimate 
of the effect of exercise and motor training indicated significantly improved balance-
related activity performance (Hedges’ g = 0.34, 95% confidence interval (CI) = 0.11 to 
0.57, P = 0.004) but there was no evidence of an effect on the proportion of fallers (risk 
ratio = 1.02; 95% CI 0.66 to 1.58, P = 0.94). Balance-related activity performance 
improved to a greater extent in the trials of programs involving highly-challenging 
balance training but the difference in effect sizes was not statistically significant (P = 
0.158). Exercise and motor training can improve the performance of balance-related 
activities in people with PD. However, further research is required to determine if falls 
can be prevented in this population. 
 
Keywords: Parkinson’s disease, exercise, motor training, balance 
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INTRODUCTION 
 Falls are a major problem for many people with Parkinson’s disease (PD).1 Reduced 
balance is known to be an important risk factor for falls in this population.2-4  Balance 
requires maintenance of the body’s centre of mass within the limits of the base of 
support while sitting or standing, and control of the centre of mass while moving to a 
new base of support during walking or running.5  Balance is often assessed with tasks 
designed to make controlling the centre of mass over the base of support difficult.6  
However, many daily activities, such as walking or standing up from a chair, are also 
balance-related as they require control of the centre of mass while moving to a new base 
of support. Therefore balance can be measured indirectly by tests of the individual’s 
ability to perform balance-related activities, particularly in individuals with impaired 
mobility.7 
 Most people with PD will ultimately develop reduced balance,8 which worsens with 
disease progression.9, 10  Reduced balance is associated with falls, poor mobility, 
disability and reduced quality of life in people with PD.2, 11-13  There is therefore a 
pressing need to explore interventions which may improve balance in this population. 
 The effect of exercise and motor training on balance in people with PD is unclear. 
Research to date has used a range of interventions and outcome measures designed to 
target and reflect balance.14-23 Nonetheless, meta-analysis is able to combine studies 
with broadly similar interventions and outcomes, and therefore provide a comprehensive 
summary of the available evidence.24  Two published meta-analyses have addressed the 
effect of exercise on PD but did not focus on balance outcomes.25, 26  One published 
review article specifically addressed the effects of exercise on balance,27 but did not 
include a meta-analysis.28 
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 Therefore, to examine whether exercise and motor training improves balance-related 
activity performance and falls in people with PD, we conducted meta-analyses of 
randomized and quasi-randomized controlled trials that assessed the efficacy of these 
interventions against no or placebo intervention. Meta-regression was used to 
investigate if the total dose of exercise and the presence of highly-challenging balance 
training were associated with the size of estimates of the effect of intervention on 
balance-related activity performance. 
 
METHODS 
Data Sources and Searches 
 A literature search was conducted on September 24th 2009 to identify studies of the 
effects of exercise and motor training in people with PD.  Databases searched were 
MEDLINE, EMBASE, AMED, PsycINFO, the Cochrane Central Register of Controlled 
Trials and CINAHL. The electronic search strategies are available as Supporting 
Information on the website.  The search was supplemented with searches of the 
Physiotherapy Evidence Database (PEDro; http://www.pedro.org.au) and examination 
of trials included in previously published systematic reviews. 25-27, 29-41  
 
Study Selection 
 Included trials were published randomized (or quasi-randomized, i.e., not truly 
random but intended to produce similar groups) controlled trials of interventions for 
people with PD.  The intervention was required to be exercise or motor training, or a 
multi-faceted intervention where most of the intervention was exercise or motor training 
and there was an aim (explicit or implicit) to improve performance of balance-related 
activities for at least 50% of the intervention (including cueing, strength and fitness 
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training).  The effects of the intervention were required to be compared with a no 
intervention or placebo control group (including social support or ‘interest’ talks) and 
the ongoing effects of the intervention were evaluated with a measure of balance or a 
balance-related activity.  Trials evaluating the effect of whole body vibration were 
excluded as this was not considered to be exercise or motor training.   
 To determine eligibility, trial titles and abstracts were screened independently by 
two investigators (NEA and CGC).  If it was clear that the trial did not meet the 
inclusion criteria, it was excluded.  The full article was obtained for the remaining trials.  
Further eligibility assessment was then independently conducted for these trials by two 
investigators (NEA and SSP), using a standardised form containing the details of the 
inclusion criteria.  Differences of opinion regarding trial eligibility were resolved by 
discussion with the remaining two investigators (CGC and CS). 
 
Data Extraction and Quality Assessment 
 A data extraction sheet was developed, pilot-tested on 5 randomly selected included 
trials and modified accordingly.  For each trial, one investigator (NEA) extracted all 
data and a second investigator (CS) checked the extracted data.  Discrepancies were 
resolved by discussion.  Care was taken to identify duplicate reports of trials.  Published 
data only were used. 
 Information extracted from each trial comprised a description of participants, details 
of the exercise and motor training program and details of outcome measures. The 
risk of bias from reported methodology for each trial was evaluated by one investigator 
(NEA) in consultation with the other investigators using the Cochrane risk of bias tool.24  
This tool was used to assess and report the quality of the included trials but trials were 
not excluded on the basis of this assessment. 
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Data Synthesis and Analysis 
 The primary outcome measures were determined a priori; these were balance-related 
activity performance and proportion of fallers.  The balance-related activities analysis 
involved the pooling of the most comprehensive balance measure from each trial.24 The 
measure from each trial was chosen prior to analysis according to the following order of 
priority: the Berg Balance Scale,42 the Timed Up and Go,43 gait velocity/time, turning 
time, sit to stand time, Functional Reach44 and single leg stand time.  Where a trial 
reported results for more than one of these outcomes, only the outcome of the highest 
priority was used.  
 Secondary outcome measures included individual balance-related activity 
performance measures.  These were the Berg Balance Scale, the Timed Up and Go, 
turning time, sit to stand time, Functional Reach, single leg stand time, gait 
velocity/time, step/stride length and gait cadence. 
 Trials with two different intervention groups had each intervention included in a 
separate comparison, with the number of participants in the control group divided 
equally between the comparisons and the control group mean and standard deviation left 
unchanged.24  Where a trial included two similar intervention groups, they were 
combined to create a single pair-wise comparison with the control group.24  For cross-
over studies, first phase data only was used.24  All data used was that collected 
immediately post-intervention. Where the median and inter-quartile range were reported 
and the study sample size exceeded 70, the median was used as an approximation of the 
mean and the inter-quartile range was assumed to equal 1.35 standard deviations.24, 45 
 Random effects meta-analyses were conducted using Comprehensive Meta-Analysis 
software (Version 2, Biostat, Englewood NJ). The standardized mean difference 
(Hedges’ g) was calculated for all meta-analyses except for the proportion of fallers, 
-55- 
which was calculated as a risk ratio.  Hedges’ g was calculated by the computer software 
using either the pre and post mean and standard deviations or the mean change and 
standard deviation data. For secondary outcomes, an estimate of the difference in mean 
outcome scores in the original unit of measurement was calculated by multiplying 
Hedges’ g by the largest included trial’s standard deviation at baseline.24 Statistical 
heterogeneity was quantified with the I2 and Q statistics.  Publication bias for the 
primary outcome measures were assessed using Egger’s test to determine if there is any 
evidence of a relationship between sample size and effect size.46 
   Two separate pre-specified univariate random effects meta-regressions were 
conducted to assess the associations between the total number of hours of intervention in 
the trials and the presence of highly-challenging balance training (yes or no/unclear), 
and estimates of the effect of intervention on balance-related activity performance. 
Highly-challenging balance training was defined as involving all of: movement of the 
centre of mass, narrowing of the base of support and minimizing upper limb support.47  
Sensitivity analysis was conducted to determine the effect of omitting studies for which 
the content of the balance training was unclear. All meta-regression analysis was 
conducted using the ‘metareg’ command in Stata (Version 10, College Station, TX). 
 
RESULTS 
Trial Flow and Study Characteristics 
 Searching identified 2,798 records, of which 19 were potentially appropriate for 
inclusion in a meta-analysis (Figure 1).48 Three trials were excluded from the meta-
analyses49-51 because the balance measures they reported were not able to be pooled with 
any others.  The characteristics of the included trials14, 15, 18, 19, 21, 22, 52-62 are summarized 
in Table 1. The risk of bias assessment24 for each included study is summarized in Table 
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2 and shows that 7 of the 16 trials were judged to fulfil the criteria for at least 3 of the 5 
domains, suggesting they were of moderate to high quality. The quality of a further 8 
trials was unclear as there was insufficient information in the publication to permit 
judgment regarding adherence to each domain. 
 
 
FIG. 1. PRISMA flow diagram48 showing flow of information through the review. 
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TABLE 1. Characteristics of the 16 included trials 
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ROM, range of movement; Y, yes; N, no; U, unclear - insufficient information to 
categorize; a , part 2 of trial only; SAFEx, sensory attention focused exercise; Highly-
challenging balance training, intervention described as involving all of: movement of the 
centre of mass, narrowing of the base of support and minimizing upper limb support; 
Task training (cueing), the use of cues specifically mentioned; Fitness training, aimed to 
maintain heart rate at 60% or more of maximum heart rate; Task training (movement 
strategy), the practice of strategies to facilitate functional movement specifically 
mentioned; Strength training, intervention described as involving added resistance to 
exercise; Stretching/ROM exercises, short or long duration stretches and/or range of 
movement exercises were specifically mentioned; Walking over ground/exercises, a 
walking program or walking exercises specifically mentioned; Walking treadmill, 
walking on a treadmill specifically mentioned 
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TABLE 2. Review authors’ judgments for the Cochrane risk of bias checklist24 for the 
16 trials included in the review 
 
 
 
Y, yes; N, no; U, unclear; *, outcome unable to be included in a meta-analysis as no 
or insufficient data given; a , part 2 of trial only. 
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Balance-Related Activity Performance 
 Fifteen trials14, 15, 18, 19, 21, 22, 52-57, 59-62 with outcomes associated with the performance 
of balance-related activities reported a total of 19 comparisons, involving 747 
participants.  The pooled estimate of the effect size was statistically significant in favour 
of intervention (Figure 2). There was evidence of small sample bias (Egger’s test of the 
intercept B0 = 1.72, 95% CI 0.17 to 3.27, t = 2.34, degrees of freedom (df) = 17, P = 
0.016).  The funnel plot of precision and Hedges’ g showed a disproportionate number 
of smaller studies with a larger positive effect suggesting some publication bias 
(available as Supporting Information on the website). 
 There was a moderate level of heterogeneity in the estimates (I2 = 51%, Q = 36.7, df 
= 18, P = 0.006). Meta-regression was used to investigate if differences in the total 
number of intervention hours and the presence of highly-challenging balance exercises 
contributed to this heterogeneity. Results showed that there was no association between 
the total number of intervention hours and the effect of intervention on performance of 
balance-related activities (effect of dose on Hedges’ g = -0.0002, 95% CI -0.019 to 
0.019, P = 0.982). There was a larger effect on balance-related activity performance in 
the 5 comparisons where interventions included highly-challenging balance exercises 
(Hedges’ g = 0.64, 95% CI 0.14 to 1.15, P = 0.015) than in the 14 comparisons which 
did not, or where the content of the balance exercises was unclear (Hedges’ g = 0.24, 
95% CI -0.03 to 0.51, P = 0.076).  However, the difference between the effects in these 
two groups of comparisons did not reach statistical significance (effect of highly-
challenging balance training on Hedges’ g = 0.40, 95% CI 0.17 to 0.97, P = 0.158).  
Sensitivity analysis showed that removing the comparisons in which the content of the 
balance training was unclear (Table 1) had minimal effect on this result (difference in 
Hedges’ g = 0.41, 95% CI 0.25 to 1.07, P = 0.201). 
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FIG. 2. Forest plot from the meta-analysis of exercise and motor training on measures 
of balance-related activity performance showing estimates of effect size with 95% 
confidence intervals.  Relative weight for each trial is indicated by the size of the 
corresponding square. 
 
Falls 
The proportion of fallers was reported in two trials,14, 22 involving a total of 250 
participants.  There was no evidence of an effect from intervention (Figure 3), and there 
was a moderate level of heterogeneity in the estimates (I2 = 49%, Q = 2.0, df = 1, P = 
0.16). 
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FIG. 3. Forest plot from the meta-analysis of exercise and motor training on falls 
showing estimates of effect size with 95% confidence intervals.  Relative weight for 
each trial is indicated by the size of the corresponding square. 
 
Secondary Outcome Measures 
Forest plots and approximate mean differences for the Berg Balance Scale,14, 18, 19, 21 
Timed Up and Go,18, 19, 22, 52, 60 turning time,52, 53, 57, 61 sit to stand time,57, 59 Functional 
Reach14, 22, 52, 61 and single leg stand time19, 22, 52, 57 are presented in Figure 4.  The pooled 
estimates (Hedges’ g) of effect size are all in the direction of showing favorable effects 
of intervention, however this favorable result only reached statistical significance for 
turning time (Figure 4C), representing a mean difference of approximately 1.3 s when 
turning 360 degrees. 
Variation in the estimates was minimal for turning time (I2 = 0%, Q = 0.74, df = 3, P 
= 0.90), Functional Reach (I2 = 0%, Q = 2.983, df = 3, P = 0.39) and single leg stand 
time (I2 = 0%, Q = 2.573, df = 3, P = 0.46).  There were low to moderate levels of 
heterogeneity in the estimates of the effect of intervention on sit to stand time (I2 = 37%, 
Q = 3.16, df = 2, P = 0.21) and Timed Up and Go (I2 = 42%, Q = 8.7, df = 5, P = 0.12).  
The Berg Balance Scale estimates showed a high level of heterogeneity (I2 = 75%, Q = 
12.1, df = 3, P = 0.007). 
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FIG. 4. Forest plots from the meta-analyses of exercise and motor training on secondary 
outcomes not relating to gait showing estimates of effect size with 95% confidence 
intervals and approximate mean differences. A. Berg Balance Scale; B. Timed Up and 
Go; C. turning time; D. sit to stand time; E. Functional Reach and F. single leg stand 
time. Relative weight for each trial is indicated by the size of the corresponding square. 
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Forest plots and approximate mean differences for the variables relating to gait are 
presented in Figure 5. The pooled estimates of the effect size for gait velocity/time15, 18, 
19, 21, 22, 52-57, 60-62 and step/stride length15, 18, 19, 22, 53, 56, 58, 60, 62 were statistically significant 
in favor of intervention (Figure 5A and B). For gait velocity this represented an 
improvement with intervention of approximately 0.05 m/s at preferred pace, which 
translates to a 0.7 s improvement over 10 m (based on a preferred walk velocity of 
0.845m/s). For step/stride length this represented an improvement in step length at 
preferred pace of approximately 3 cm. Similarly, there was a favorable trend towards a 
reduction in cadence15, 22, 56, 60, 62 after intervention compared with control (Figure 5C).  
There was very little heterogeneity in the estimates of the effect of intervention on gait 
(gait velocity/time I2 = 14%, Q = 17.46, df = 15, P = 0.29; step/stride length I2 = 0%, Q 
= 6.07, df = 11, P = 0.87; cadence I2 = 0%, Q = 3.499, df = 7, P = 0.84). 
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FIG. 5. Forest plots from the meta-analyses of exercise and motor training on secondary 
outcomes relating to gait showing estimates of effect size with 95% confidence intervals 
and approximate mean differences. A. gait velocity/time; B. step/stride length and C. 
cadence. Relative weight for each trial is indicated by the size of the corresponding 
square. 
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DISCUSSION 
This systematic review provides evidence that exercise and motor training can 
improve performance of balance-related activities in people with PD. However, it 
remains unclear whether exercise and motor training can reduce falls in this population. 
Exercise and motor training were found to have a small positive effect on balance-
related activity performance, gait velocity and step/stride length, as well as a moderate 
effect on turning time. The meta-regression results suggest that the inclusion of highly-
challenging balance training may improve the efficacy of intervention on balance-
related activity performance but this requires further investigation. 
This is the first systematic review to conduct meta-analyses of the effect of exercise 
and motor training on the performance of balance-related activities. The results of this 
review uphold and quantify the results of the recent narrative review suggesting positive 
effects from exercise on balance in PD.27  In the current review, the measure of balance-
related activity performance included 15 trials with a total of 747 participants. While the 
overall quality of 8 of the included trials was unclear, the remaining 7 trials were of 
moderate to good quality (Table 2). However, the included trials do show some 
evidence of publication bias, with some small studies having a relatively large positive 
effect size. These results should therefore be interpreted cautiously and generalized only 
to people with mild to moderate PD. 
There was no evidence from this review that exercise and motor training can reduce 
falls in people with PD. However, of the two trials included in the meta-analysis on 
falls, one did not include highly challenging balance exercises and did not aim to reduce 
falls,22 while the type of balance training used in the other trial was unclear.14 However, 
results of this review do suggest that exercise and motor training may improve balance, 
and balance is known to be an important risk factor for falls in this population.2-4 
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Furthermore, exercise has been shown to reduce falls in the general older population.47, 
63  For these reasons, further research is required to determine if falls can be prevented 
in people with PD. 
As expected, there was a moderate to high level of heterogeneity in the meta-
analyses of this review. We suggest that despite this heterogeneity, random effects meta-
analysis is appropriate as all included studies had broadly similar outcomes and 
interventions, i.e. they targeted balance-related activities.64  We used meta-regression to 
investigate whether this heterogeneity could be explained by differences in exercise 
program design and found an indication of a bigger effect of exercise on balance-related 
activity performance if highly-challenging balance training was included. However, this 
difference in the effect in trials with and without highly-challenging balance training did 
not reach statistical significance. There were not enough trials to conduct meta-
regression analyses on the secondary outcome measures but the high level of 
heterogeneity in the Berg Balance Scale analysis may reflect the fact that of the four 
pooled trials, only two included highly-challenging balance training.18, 19 
These results suggest that therapists should consider including highly-challenging 
balance training in exercise programs for people with PD. Although many forms of 
exercise and motor training improve the performance of balance-related activities in this 
population, exercise which specifically involves movement of the centre of mass, 
narrowing of the base of support and minimizing upper limb support may produce the 
best results. While this result is encouraging, the progressive nature of PD means that 
balance training would be required to be ongoing. Providing highly-challenging balance 
training in a sustainable way for this population is problematic as it is difficult to 
achieve the required level of challenge while maintaining safety in group or semi-
supervised home-based programs. Future research working towards the development of 
-68- 
effective programs which are sustainable for the long term would be an important step in 
solving this problem. 
Most of the effect sizes found in these meta-analyses were small to moderate 
(Hedges’ g = 0.2 to 0.5) but do represent a meaningful improvement in the outcome 
measure (e.g. a 0.05 m/s improvement in gait velocity has been shown to be meaningful 
in older adults.)65  Larger effects have been found to occur with more intense 
interventions following stroke66 and in the general older population,47 and this may also 
be true of people with PD.  Trials included in the current review averaged 18 hours of 
intervention over 7 weeks. This overall low dose of intervention may also explain why 
the total dose of exercise was not associated with the effect of intervention on 
performance of balance-related activities. Future research needs to examine the effect of 
using a higher dose of intervention on balance outcomes and the performance of 
balance-related activities. 
In conclusion, exercise and motor training can improve the performance of balance-
related activities in people with PD. We recommend that highly-challenging balance 
exercises be part of rehabilitation programs for people with PD. It is now important to 
develop effective, sustainable programs that people with PD can participate in for the 
long term, and to assess the effect of these programs on falls rates. The development of 
such programs may have a widespread and ongoing impact in improving the quality of 
life of people with PD and their families as well as easing demands on healthcare 
systems. 
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Appendix – Online Supplementary Information 
SEARCH STRATEGIES 
Search filters developed by the Scottish Intercollegiate Guidelines Network (SIGN; 
http://www.sign.ac.uk/methodology/filters.html) to identify randomized trials were 
included in the search strategies. There were no restrictions on language or publication 
date. 
 
Search Strategy: MEDLINE (1950 to present) (OVID) 
 
1     Parkinson's disease.mp. or exp Parkinson Disease/ 
2     (Parkinson$ adj1 disease).mp. 
3     1 or 2 
4     exp Accidental Falls/ 
5     fall$.mp. 
6     exp Exercise/ 
7     rehabilitation.mp. or exp Rehabilitation/ 
8     exp "Physical Therapy (Specialty)"/ or exp Physical Therapy Modalities/ or 
physical therapy.mp. 
9     exp Postural Balance/ 
10     exp Resistance Training/ 
11     exp Motor Activity/ 
12     exp Cues/ 
13     exercis$.mp. 
14     train$.mp. 
15     therap$.mp. 
16     physiother$.mp. 
17     physical ther$.mp. 
18     balanc$.mp. 
19     strength$.mp. 
20     11 or 7 or 17 or 18 or 16 or 13 or 6 or 9 or 12 or 14 or 15 or 8 or 4 or 10 or 19 or 5 
21     3 and 20 
22     exp Deep Brain Stimulation/ 
23     exp Drug Evaluation/ 
24     exp Drug Approval/ 
25     exp Antiparkinson Agents/ 
26     exp Stem Cells/ 
27     exp Gene Therapy/ 
28     exp Alzheimer Disease/ 
29     27 or 25 or 22 or 28 or 24 or 26 or 23 
30     21 not 29 
31     randomized controlled trials as topic/ 
32     randomized controlled trial/ 
33     random allocation/ 
34     double-blind method/ 
35     Single-Blind Method/ 
36     clinical trial/ 
37     exp clinical trials as topic/ 
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38     (clinic$ adj trial$1).tw. 
39     ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw. 
40     placebos/ 
41     placebo$.tw. 
42     randomly allocated.tw. 
43     (allocated adj2 random).tw. 
44     35 or 33 or 32 or 39 or 40 or 36 or 41 or 42 or 38 or 34 or 37 or 43 or 31 
45     30 and 44 
46     limit 45 to humans 
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Search Strategy: EMBASE (1980 to present) (OVID) 
 
1     Parkinson's disease.mp. or exp Parkinson disease/ 
2     (Parkinson$ adj1 disease).mp. 
3     1 or 2 
4     exp falling/ 
5     fall$.mp. 
6     exp exercise/ or exp treadmill exercise/ or exp leg exercise/ 
7     exp kinesiotherapy/ 
8     rehabilitation.mp. or exp rehabilitation/ 
9     physiotherapy.mp. or exp physiotherapy/ 
10     exp physical education/ 
11     exp balance disorder/ 
12     exp body equilibrium/ 
13     exp "physical activity, capacity and performance"/ 
14     exp muscle strength/ 
15     exp motor activity/ 
16     exp motor control/ 
17     exp association/ 
18     exercis$.mp. 
19     train$.mp. 
20     therap$.mp. 
21     physiother$.mp. 
22     "physical ther$".mp. 
23     balanc$.mp. 
24     strength$.mp. 
25     11 or 21 or 7 or 17 or 22 or 18 or 23 or 16 or 13 or 6 or 9 or 12 or 20 or 14 or 15 
or 8 or 4 or 24 or 10 or 19 or 5 
26     25 and 3 
27     exp brain depth stimulation/ 
28     exp drug analysis/ 
29     exp drug research/ 
30     exp drug approval/ or exp drug monitoring/ 
31     exp antiparkinson agent/ 
32     exp stem cell/ 
33     exp gene therapy/ 
34     exp Alzheimer disease/ 
35     27 or 33 or 32 or 28 or 34 or 30 or 29 or 31 
36     26 not 35 
37     clinical trial/ 
38     randomized controlled trial/ 
39     exp randomization/ 
40     single blind procedure/ 
41     double blind procedure/ 
42     crossover procedure/ 
43     placebo/ 
44     randomi?ed controlled trial$.tw. 
45     RCT.tw. 
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46     random allocation.tw. 
47     randomly allocated.tw. 
48     allocated randomly.tw. 
49     (allocated adj2 random).tw. 
50     single blind$.tw. 
51     double blind$.tw. 
52     ((treble or triple) adj blind$).tw. 
53     placebo$.tw. 
54     prospective study/ 
55     53 or 48 or 42 or 46 or 44 or 50 or 39 or 40 or 51 or 41 or 47 or 38 or 52 or 49 or 
37 or 45 or 43 or 54 
56     36 and 55 
57     limit 56 to human 
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Search Strategy: AMED (1985 to present) (OVID) 
 
1     exp Parkinson disease/ or Parkinson's disease.mp. 
2     (Parkinson$ adj1 disease).mp. 
3     1 or 2 
4     exp Exercise/ or exp Rehabilitation/ 
5     physical therapy.mp. 
6     physiotherapy.mp. 
7     exp Kinematics/ 
8     exp Accidental falls/ 
9     fall$.mp. 
10     exp Resistance training/ 
11     exp Motor skills/ 
12     exp Cues/ 
13     exercis$.mp. 
14     train$.mp. 
15     therap$.mp. 
16     physiother$.mp. 
17     physical ther$.mp. 
18     balanc$.mp. 
19     strength$.mp. 
20     11 or 7 or 17 or 18 or 16 or 13 or 6 or 9 or 12 or 14 or 15 or 8 or 4 or 10 or 19 or 5 
21     3 and 20 
22     exp Neurosurgery/ 
23     deep brain stimulation.mp. 
24     exp Drug therapy/ 
25     exp Antiparkinson agents/ 
26     exp germ cells/ 
27     exp gene therapy/ 
28     exp Alzheimers disease/ 
29     27 or 25 or 22 or 28 or 24 or 26 or 23 
30     21 not 29 
31     exp Clinical trials/ 
32     exp Randomized controlled trials/ 
33     exp Double blind method/ 
34     exp Placebos/ 
35     exp Random allocation/ 
36     exp Comparative study/ 
37     (clinical trial$ or randomi$ed controlled trial or controlled clinical trial).pt. 
38     (crossover or cross-over or cross over).tw. 
39     (random$ or placebo$ or (clin$ adj1 trial$)).ab,ti. 
40     ((singl$ or doubl$ or trebl$ or tripl$) adj1 (blind$ or mask$)).ab,ti. 
41     35 or 33 or 32 or 39 or 40 or 36 or 38 or 34 or 37 or 31 
42     30 and 41 
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Search Strategy: PsycINFO (1806 to present) (OVID) 
  
1     Parkinson's disease.mp. or exp Parkinsons Disease/ 
2     (Parkinson$ adj1 disease).mp. 
3     1 or 2 
4     exp Falls/ 
5     fall$.mp. 
6     exp Physical Activity/ 
7     exp Rehabilitation/ or rehabilitation.mp. 
8     physical therapy.mp. or exp Physical Therapy/ 
9     exp Equilibrium/ 
10     exp Athletic Training/ or exp Training/ 
11     exp Physical Strength/ 
12     exp Physical Fitness/ 
13     exp Motor Coordination/ 
14     exp Perceptual Motor Learning/ 
15     exp Cues/ 
16     exercis$.mp. 
17     train$.mp. 
18     therap$.mp. 
19     physiother$.mp. 
20     physical ther$.mp. 
21     balanc$.mp. 
22     strength$.mp. 
23     11 or 21 or 7 or 17 or 22 or 18 or 16 or 13 or 6 or 9 or 12 or 20 or 14 or 15 or 8 or 
4 or 10 or 19 or 5 
24     3 and 23 
25     exp Electrical Brain Stimulation/ 
26     exp Drug Therapy/ 
27     antiparkinson agent.mp. 
28     exp Stem Cells/ 
29     exp Gene Therapy/ 
30     exp Alzheimers Disease/ 
31     27 or 25 or 28 or 30 or 26 or 29 
32     24 not 31 
33     exp Placebo/ 
34     exp Experiment Controls/ 
35     exp Clinical Trials/ 
36     (crossover or cross-over or cross over).tw. 
37     (random$ or placebo$ or (clin$ adj1 trial$)).ab,ti. 
38     35 or 33 or 34 or 36 or 37 
39     38 and 32 
40     limit 39 to human 
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Search Strategy: Cochrane Central Register of Controlled Trials (dates not 
provided) (OVID) 
 
1     Parkinson's disease.mp. or exp Parkinson Disease/ 
2     (Parkinson$ adj1 disease).mp. 
3     1 or 2 
4     exp Exercise Movement Techniques/ 
5     exp Rehabilitation/ 
6     exp Physical Therapy Modalities/ or physical therapy.mp. 
7     exp Accidental Falls/ 
8     fall$.mp. 
9     exp musculoskeletal equilibrium/ 
10     exp Muscle Strength/ 
11     exp Motor Activity/ 
12     exp Cues/ 
13     exercis$.mp. 
14     train$.mp. 
15     therap$.mp. 
16     physiother$.mp. 
17     physical ther$.mp. 
18     balanc$.mp. 
19     strength$.mp. 
20     11 or 7 or 17 or 18 or 16 or 13 or 6 or 9 or 12 or 14 or 15 or 8 or 4 or 10 or 19 or 5 
21     3 and 20 
22     exp Deep Brain Stimulation/ 
23     exp Drug Evaluation/ 
24     exp Antiparkinson Agents/ 
25     exp Stem Cells/ 
26     exp Gene Therapy/ 
27     exp Alzheimer Disease/ 
28     27 or 25 or 22 or 24 or 26 or 23 
29     21 not 28 
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Search Strategy: CINAHL (1982 to present) (EBSCO) 
 
S1 ("Parkinson's disease") or (MH "Parkinson Disease") 
S2 ""Parkinson* disease"" 
S3 S1 or S2 
S4 (MH "Accidental Falls") 
S5 ""fall*"" 
S6 (MH "Exercise+") 
S7 (MH "Rehabilitation+") 
S8 (MH "Physical Therapy+") 
S9 (MH "Balance Training, Physical") or (MH "Balance, Postural") 
S10 (MH "Posturography") 
S11 (MH "Therapeutic Exercise+") or (MH "Exercise Therapy: Ambulation (Iowa 
NIC)") or (MH "Exercise Therapy: Balance (Iowa NIC)") or (MH "Exercise 
Therapy: Joint Mobility (Iowa NIC)") or (MH "Exercise Therapy: Muscle 
Control (Iowa NIC)") 
S12 (MH "Motor Activity+") or (MH "Motor Skills+") 
S13 (MH "Cues") 
S14 (MH "Physical Fitness+") 
S15 ""exercis*"" 
S16 ""train*"" 
S17 ""therap*"" 
S18 ""physiother*"" 
S19 ""physical ther*"" 
S20 ""balanc*"" 
S21 ""strength*"" 
S22 S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or 
S16 or S17 or S18 or S19 or S20 or S21 
S23 S3 and S22 
S24 (MH "Deep Brain Stimulation") 
S25 (MH "Antiparkinson Agents+") 
S26 (MH "Stem Cells+") 
S27 (MH "Gene Therapy") 
S28 (MH "Alzheimer's Disease") 
S29 S24 or S25 or S26 or S27 or S28 
S30 S23 not S29 
S31 (MH "Clinical Trials+") 
S32 PT clinical trial 
S33 (MH "Placebos") 
S34 (MH "Random Assignment") 
S35 (MH "Control Group") 
S36 (MH "Crossover Design") 
S37 ""randomi*ed control* trial*"" 
S38 ""singl* blind*"" 
S39 ""doubl* blind*"" 
S40 ""tripl* blind*"" 
S41 ""trebl* blind*"" 
S42 ""singl* mask*"" 
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S43 ""doubl* mask*"" 
S44 ""tripl* mask*"" 
S45 ""trebl* mask*"" 
S46 "random*" 
S47 ""placebo*"" 
S48 ""clin* trial"" 
S49 S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41 or 
S42 or S43 or S44 or S45 or S46 or S47 or S48 
S50 S30 and S49 
S51 (MH "Animals+") 
S52 S50 not S51 
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FUNNEL PLOT ASSESSING PUBLICATION BIAS 
 
 
Supplemental FIG. 1. Funnel plot of precision by Hedges’ g for meta-analysis of the 
effect of exercise and motor training on balance-related activity performance. 
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CHAPTER 4 
 
Bradykinesia, muscle weakness and reduced muscle 
power in Parkinson’s disease 
 
 
 
 
Chapter 4 has been published as: 
Allen NE, Canning CG, Sherrington C, Fung VSC (2009) Bradykinesia, muscle 
weakness and reduced muscle power in Parkinson’s disease. Movement Disorders 
24(9): 1344-1351. 
 
A supplementary file (Methods used to measure muscle strength and power) was 
published online with this publication. It is placed as an appendix at the end of this 
chapter. 
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The published paper and online supplementary file were included in the thesis here. 
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CHAPTER 5 
 
Reduced muscle power is associated with slower 
walking velocity and falls in people with 
Parkinson’s disease 
 
 
 
 
Chapter 5 has been published as: 
Allen NE, Sherrington C, Canning CG, Fung VSC (2010) Reduced muscle power is 
associated with slower walking velocity and falls in people with Parkinson’s disease. 
Parkinsonism and Related Disorders 16(4):261-264.   
 
Unpublished findings from this study are placed as an appendix at the end of this 
chapter. They were not included in the publication due to the journal’s word count 
limitations. 
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The published paper was included in the thesis here. 
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Appendix - Unpublished findings 
Introduction 
Some details of the statistical analysis conducted for this project were unable to be 
included in the journal article due to the journal’s word count limitations. These 
additional details include further results of the regression analysis analysing associations 
between muscle power/strength and walking velocity as well as muscle power/strength 
and past falls. Additionally, a regression analysis of the associations between asymmetry 
of leg extensor muscle power/strength and past falls is presented.  
 
Asymmetry of muscle power appears to be an important risk factor for falls in the 
general older population.1,2 Many people with Parkinson’s disease present with 
asymmetrical symptoms. However, it remains undetermined if asymmetry of lower limb 
extensor muscle strength or power is predictive of falls in people with Parkinson’s 
disease. Consequently we aimed to determine if there is an association between 
asymmetry of leg extensor muscle strength or power and falls in people with 
Parkinson’s disease. 
 
Methods 
The methods used for this study have been described in Chapters 4 and 5. Muscle 
strength and peak power asymmetry were measured as the difference between the legs 
as a percentage of the stronger leg. 
 
Statistical Analysis 
Associations between muscle strength / peak power asymmetry and past falls were 
explored using univariate logistic regression models.  Participants were categorised as 
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having had 0-1 falls or multiple falls (≥ 2 falls).  Muscle strength and peak power 
asymmetry were dichotomised into two equal groups to give a “low” and “high” 
grouping for each variable.  Data were analysed using SPSS statistical software 
(Version 14, Chicago IL). 
 
Results 
Associations between UPDRS motor score and strength/power 
Only 3% of the variability in muscle strength was explained by UPDRS motor score (p 
= 0.268, R2 = 0.03).  UPDRS motor score explained 6-9% of the variability in muscle 
power (peak power p=0.14, R2 = 0.06, power at 30% 1RM p = 0.06, R2 = 0.09). 
 
Associations between strength/power and walking velocity 
Muscle power explained up to 33% of the variance in comfortable walking velocity, but 
up to 54% of the variance in maximal walking velocity.  Muscle power was a greater 
predictor of walking velocity than muscle strength at both walking velocities (Table 1).  
For comfortable walking velocity, the UPDRS motor score explained 6-11% more 
variability than muscle power.  For maximal walking velocity the opposite was true, 
with 19-23% more variance explained by muscle power than the UPDRS.  Age and 
height both explained less variance than muscle strength, power or the UPDRS motor 
score for both walking velocities. 
 
Maximal power at 30% 1RM explained more of the variance in both comfortable and 
maximal walking velocities than peak power.  For this reason, maximal power at 
30%1RM was used for the remaining analysis of walking velocity.   
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Table 1.  Associations between predictor variables and walking velocity from 
univariate linear regression models 
 R2 
(p) 
Coefficient 
(95% CI) 
SD of 
predictor 
variable 
Change in 
10m velocity 
(m/s) per SD 
Comfortable walking velocity 
Leg power at peak power (W) 
 
 
Leg power at 30% 1RM (W) 
 
 
Leg strength (N) 
 
 
UPDRS motor  
 
 
Age (y) 
 
 
Height (m) 
 
0.28 
(0.001) 
 
0.33 
(<0.001) 
 
0.26 
(0.001) 
 
0.39 
(<0.001) 
 
0.04 
(0.2) 
 
0.14 
(0.02) 
 
0.0007 
(0.0003 to 0.0011) 
 
0.001 
(0.0005 to 0.0014) 
 
0.0004 
(0.0002 to 0.0007) 
 
-0.0169 
(-0.0238 to -0.01) 
 
-0.0068 
(-0.0173 to 0.0038) 
 
1.0379 
(0.1792 to 1.8967) 
 
186.3 
 
 
150.8 
 
 
305.7 
 
 
9.52 
 
 
7.83 
 
 
0.09 
 
0.14 
 
 
0.15 
 
 
0.13 
 
 
-0.16 
 
 
-0.05 
 
 
0.09 
 
 
Maximal walking velocity 
Leg power at peak power (W) 
 
 
Leg power at 30% 1RM (W) 
 
 
Leg strength (N) 
 
 
UPDRS motor  
 
 
Age (y) 
 
 
Height (m) 
 
 
 
0.50 
(<0.001) 
 
0.54 
(<0.001) 
 
0.43 
(<0.001) 
 
0.31 
(<0.001) 
 
0.12 
(0.03) 
 
0.24 
0.001 
 
 
0.0014 
(0.001 to 0.0019) 
 
0.0018 
(0.0013 to 0.0024) 
 
0.0008 
(0.0005 to 0.0011) 
 
-0.0219 
(-0.0327 to -0.011) 
 
-0.017 
(-0.0318 to -0.0021) 
 
2.0243 
(0.8417 to 3.207) 
 
 
186.3 
 
 
150.8 
 
 
305.7 
 
 
9.52 
 
 
7.83 
 
 
0.09 
 
 
0.27 
 
 
0.28 
 
 
0.25 
 
 
-0.21 
 
 
-0.13 
 
 
0.19 
CI, confidence interval; SD, standard deviation; UPDRS, Unified Parkinson’s Disease 
Rating Scale; 1RM, 1 repetition maximum 
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When a second predictor variable was added to the models (Table 2), the model 
explaining the largest amount of variance in walking velocity included leg muscle power 
and UPDRS motor score, explaining 66% of the variance in maximal walking velocity.  
The associations between muscle power/strength and walking velocity remained 
statistically significant at both walking velocities after adjusting for UPDRS motor 
score.  The adjusted models show a one standard deviation change in muscle power at 
30% 1RM produced a larger change in 10m velocity than a one standard deviation 
change in muscle strength at maximal walking velocity. 
 
The associations between muscle power/strength and walking velocity also remained 
statistically significant after adjusting for age or height.  Neither age nor height made a 
significant independent contribution in the multivariate models. 
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Table 2.  Associations between predictor variables and walking velocity from 
multivariate linear regression models 
 Model R2 
(Model p)
Coefficients of 
predictor variables 
(95% CI) 
p of 
predictor 
variables 
SD of 
predictor 
variables 
Change in 
10m velocity 
(m/s) per SD 
Comfortable 
walking velocity 
 
Leg power at 
30% 1RM (W) 
adjusted for 
UPDRS motor 
 
 
Leg strength 
(N)  
 adjusted for 
UPDRS motor 
 
 
 
 
0.56 
(<0.001) 
 
 
 
 
0.56 
(<0.001) 
 
 
 
0.0007 
(0.0003 to 0.0011) 
 
-0.0134 
(-0.0197 to -0.0071) 
 
0.0003 
(0.0002 to 0.0005) 
 
-0.0149 
(-0.021 to -0.0088) 
 
 
 
 
0.001 
 
 
<0.001 
 
 
0.001 
 
 
<0.001 
 
 
 
 
 
150.75 
 
 
9.52 
 
 
305.67 
 
 
9.52 
 
 
 
 
0.11 
 
 
-0.13 
 
 
0.11 
 
 
-0.14 
 
Maximal walking 
velocity 
 
Leg power at 
30% 1RM (W) 
adjusted for 
UPDRS motor 
 
 
Leg strength  
(N) 
adjusted for 
UPDRS motor 
 
 
 
 
0.66 
(<0.001) 
 
 
 
 
0.62 
(<0.001) 
 
 
 
 
 
 
0.0016 
(0.0011 to 0.0021) 
 
-0.0144 
(-0.0225 to -0.0063) 
 
0.0007 
(0.0005 to 0.001) 
 
-0.0178 
(-0.0261 to -0.0096) 
 
 
 
 
<0.001 
 
 
0.001 
 
 
<0.001 
 
 
<0.001 
 
 
 
 
 
150.75 
 
 
9.52 
 
 
305.67 
 
 
9.52 
 
 
 
 
 
0.24 
 
 
-0.14 
 
 
0.22 
 
 
-0.17 
 
 
CI, confidence interval; SD, standard deviation; UPDRS, Unified Parkinson’s Disease 
Rating Scale; 1RM, 1 repetition maximum 
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Associations between strength/power and falls 
Participants with low peak power or low maximal power at 30% 1RM were 6 times 
more likely to have experienced multiple falls in the past year than participants with 
high power measurements (Table 3).  Participants with a high UPDRS motor score were 
also 6 times more likely to have experienced multiple falls in the past year than 
participants with a low UPDRS motor score.  There was an association between low 
strength and past multiple falls, but this did not reach statistical significance.  There was 
no association between older age and past multiple falls. 
 
In multivariate models, the association between power and falls was not statistically 
significant after adjustment for UPDRS motor score (low maximal power at 30% 1RM, 
OR = 1.0, 95% CI 0.99 to 1.0, p=0.09).  However UPDRS motor score continued to 
have an independent relationship with falls (high UPDRS motor score, OR = 1.1, 95% 
CI 1.0 to 1.3, p=0.028) in the model with both power at 30% 1RM and UPDRS motor 
score as predictor variables.  In contrast, the association between power and falls 
remained statistically significant after adjustment for age (low maximal power at 30% 
1RM OR = 5.9, 95% CI 1.05 to 33.03, p=0.04), which did not make an important 
contribution to the model (OR = 1.0, 95% CI 0.9 to 1.1, p = 0.86). 
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Table 3.  Associations between dichotomized predictor variables and multiple falls in 
the past year from univariate logistic regression models 
Dichotomized Predictors Odds Ratio 
(95% CI) 
P 
 
Low peak power 
 
6.0 
(1.08 to 33.27) 
 
0.04 
 
Low maximal power at 
30% 1RM 
 
6.0 
(1.08 to 33.27) 
 
0.04 
 
Low strength 
 
3.1 
(0.66 to 14.14) 
 
0.15 
 
High UPDRS motor score 
 
6.0 
(1.08 to 33.27) 
 
0.04 
 
Older age 
 
1.0 
(0.24 to 4.18) 
 
1.0 
CI, confidence interval; SD, standard deviation; UPDRS, Unified Parkinson’s Disease 
Rating Scale; 1RM, 1 repetition maximum 
Strength measured in Newtons, Power measured in Watts. 
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Association between asymmetry of muscle strength/peak power and falls 
No clear conclusion could be reached about the association between high strength 
asymmetry and high peak power asymmetry and past multiple falls (Table 4).  
 
Table 4.  Associations between dichotomised predictor variables and multiple falls in 
the past year from univariate logistic regression models 
Dichotomised Predictors Odds Ratio 
(95% CI) 
P 
 
High peak power 
asymmetry 
 
1.7 
(0.4 to 7.34) 
 
0.47 
 
High strength asymmetry 
 
1.7 
(0.4 to 7.34) 
 
0.47 
CI, confidence interval 
Power measured in Watts, Strength measured in Newtons. 
Asymmetry measured as the difference between the legs as a percentage of the 
stronger leg. 
 
Conclusion 
Additional unpublished detail of the regression analyses has been presented. Given the 
low association between the UPDRS motor score and muscle power and the fact that the 
UPDRS eliminates the association between muscle power and past falls, it is likely that 
other factors contributing to the UPDRS motor score are more strongly associated with 
past falls.  
 
In the present study there was no evidence for an association between falls and leg 
extensor muscle strength or peak power asymmetry in people with Parkinson’s disease.  
The sample size of the present study may have been too small to detect these 
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relationships and so the possibility of an association between falls and muscle strength 
or power asymmetry should not be discounted. 
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CHAPTER 6 
 
Conclusion 
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OVERVIEW 
This thesis reports the results of three studies that were conducted with the broad aim of 
evaluating and exploring interventions with the potential to reduce fall risk in people 
with Parkinson’s disease. The aim of the first study was to compare a six-month 
exercise program which targeted potentially remediable risk factors for falls with usual 
care in a randomised controlled trial involving people with Parkinson’s disease who had 
fallen or were at risk of falling (Chapter 2). Participants randomised to the exercise 
group showed a 7% (not statistically significant) reduction in fall risk, though the 
clinical relevance of this small reduction is unclear. The exercise group did, however, 
display improvements in freezing of gait and sit to stand time, as well as trends towards 
improvement in knee extensor muscle strength, fast walking speed and fear of falling. 
These outcomes were achieved safely at home using a pragmatic, minimally-supervised 
exercise program, with no exercise participants falling while carrying out the exercises.  
 
The aim of the second study was to rigorously examine the current evidence for the 
effectiveness of exercise and motor training on the performance of balance-related 
activities in people with Parkinson’s disease via a systematic review with meta-analyses 
(Chapter 3). The review found evidence that exercise and motor training can improve 
performance of balance-related activities in people with Parkinson’s disease. 
Furthermore, it appears that the inclusion of highly-challenging balance training may 
enhance the effect of intervention on the performance of balance-related activities. 
However, further research is required to determine if exercise and motor training can 
reduce falls in people with Parkinson’s disease.  
 
-109- 
The final study had two parts which were presented separately (Chapters 4 and 5). The 
aims of the first part were to determine if people with mild to moderate Parkinson’s 
disease are weaker and/or less powerful than a neurologically-normal control group and 
to determine the relative contributions of force and movement velocity to muscle power 
in people with Parkinson’s disease (Chapter 4). The leg extensor muscles of the 
Parkinson’s disease group were 16% weaker and 22% less powerful than the control 
group. Muscle weakness was found to contribute to reduced muscle power at all loads. 
However, muscle power was disproportionately reduced at light to medium loads due to 
decreased movement speed, suggesting that bradykinesia (ie, slowed muscle 
contraction) was making an additional contribution to reduced power over and above 
weakness at light and medium, but not heavy, loads.  This is likely to be important as 
many daily activities, including stepping to prevent a fall, appear to depend on the 
ability to use muscles quickly at light to medium loads. 
 
The second part of the final study investigated the relationships between leg extensor 
muscle strength and power with walking speed and past falls in people with mild to 
moderate Parkinson’s disease (Chapter 5).  Muscle power was consistently found to 
explain as much or more of the variation in walking velocity, and was more strongly 
associated with past falls, than muscle strength.  More than half the variance in walking 
velocity was explained by muscle power, and this association remained significant in 
models which included the severity of Parkinson’s disease motor symptoms.  
Furthermore, participants with low muscle power were six times more likely to report 
multiple falls in the prior 12 months than those with high muscle power, though this 
association between falls and power was no longer significant in models which included 
the severity of Parkinson’s disease motor symptoms. Sound leg extensor muscle power 
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therefore seems likely to be important for maximising mobility in people with 
Parkinson’s disease, though its value in reducing falls requires further prospective 
investigation. 
 
CLINICAL IMPLICATIONS AND SUGGESTIONS FOR FUTURE RESEARCH 
Several important themes with implications for the provision of exercise programs and 
future research into exercise to reduce fall risk and prevent falls in people with 
Parkinson’s disease arise from the work presented in this thesis. Firstly, targeted 
exercise may reduce overall fall risk and is able to improve muscle strength, freezing of 
gait and performance of balance-demanding activities in people with Parkinson’s 
disease. However, the ability of exercise to reduce falls in this population remains 
unclear. Secondly, many people with Parkinson’s disease who are at risk of falling but 
who have sufficient cognition are able to exercise safely at home. Finally, reduced 
muscle power is also likely to be a risk factor for falls and the effect of muscle power 
training on falls and fall risk warrants investigation. 
 
The high prevalence of falls1-5 and the persistence of falls despite advances in medical 
care5-10 underscore the importance of the development of effective exercise interventions 
to reduce falls in people with Parkinson’s disease. Work presented in this thesis suggests 
that exercise may reduce fall risk in Parkinson’s disease by improving remediable fall 
risk factors, namely leg muscle strength, freezing of gait and balance. The exercise 
program employed in the randomised controlled trial (Chapter 2) resulted in the exercise 
group achieving a 7% (not statistically significant) reduction in fall risk, falling well 
short of the 20% reduction anticipated from studies with the general older population.11, 
12 However, the exercise group did show a strong trend towards an improvement in knee 
-111- 
extensor muscle strength using weighted vests and an improvement in freezing of gait 
using cueing intervention modelled on that described in the successful RESCUE trial.13  
The exercise program did not provide evidence for an improvement in standing and 
leaning balance, but did provide evidence for an improvement in the performance of 
balance-related activities, with significantly faster sit to stand time and a trend towards 
faster walking speeds. Furthermore, results from the systematic review (Chapter 3) 
confirmed that exercise, particularly highly-challenging balance exercise, can improve 
the performance of balance-related activities in people with Parkinson’s disease. These 
results suggest that physiotherapists should prescribe carefully designed exercise 
programs that target these remediable fall risk factors for people with Parkinson’s 
disease who are at risk of falling.  
 
A limitation of the randomised controlled trial presented in Chapter 2 is the Parkinson’s 
disease fall risk score that was used as the primary outcome measure. This fall risk score 
was designed to identify individuals at risk of falling14 rather than detect change in fall 
risk. One consequence of this is that the score components are constrained, utilising 
knee extensor muscle strength of only the weaker leg, balance measured as coordinated 
stability and freezing of gait measured as a yes/no response. While the exercise group 
did show trends towards improvements in knee extensor muscle strength and significant 
improvements in freezing of gait, the strength improvement was largest for the stronger 
leg and the improvements in freezing of gait were detected using the Freezing of Gait 
Questionnaire,15 as the yes/no response was not sensitive enough to detect this 
improvement. It is recommended that this fall risk score be re-examined and 
significantly modified before use as a primary outcome measure in future intervention 
studies. 
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There was a small amount of data missing from the randomised controlled trial (Chapter 
2) as three intervention group participants dropped out and were unavailable for post-
intervention testing. However, the treatment of missing outcome data in randomised 
trials is controversial and there are limitations of current imputation methods.16 Thus it 
was decided a priori not to impute missing data. 
 
While knee extensor muscle strength did show a trend towards improvement following 
the exercise intervention in the randomised controlled trial (Chapter 2), these 
improvements were small and did not reach statistical significance. This result may have 
been in part due to the use of a strain gauge to measure knee extensor muscle strength. 
While these tools were calibrated and are reliable,17  they measure muscle strength on a 
relatively small scale and so might give less precise results than more sophisticated 
equipment, such as variable resistance machines, which measure strength on a larger 
scale (Study 3, Chapters 4 and 5). However, as the randomised controlled trial was a 
pragmatic, largely home-based trial, measurements were made in participants’ homes, 
necessitating the use of portable equipment. It would be interesting for future work into 
the effects of pragmatic strength training with weighted vests to compare the amount of 
improvement measured with the strain gauge against that measured with a variable 
resistance machine. 
 
The lack of improvement in standing and leaning balance after the exercise intervention 
employed in the randomised controlled trial (Chapter 2) was surprising and perplexing, 
particularly as measures of performance of balance-related activities did improve. This 
apparent lack of improvement in balance outcomes may have been due to the nature of 
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outcome measures. The balance outcome measures used are commonly used in people 
with Parkinson’s disease and in the general older population for both research and 
clinical purposes. Furthermore, the coordinated stability test, postural sway and maximal 
balance range in standing have all recently been found to improve with exercise in older 
people following discharge from hospital.12 However, these measures may be less 
suitable to detect improvements in people with Parkinson’s disease. For example, while 
increased postural sway has been found to be associated with increased disease severity 
and increased fall risk,18-22 people with Parkinson’s disease can present with an 
abnormal increase or decrease in postural sway.18, 23, 24 Similarly, coordinated stability 
and maximal balance range may be problematic measures in people with Parkinson’s 
disease since people with Parkinson’s disease have difficulty estimating their limits of 
stability.25 
 
The measures used in the trials included in the systematic review presented in Chapter 3 
may provide insights regarding outcome measures to be included in future intervention 
studies. The primary outcome measure of balance-related activity performance involved 
pooling one balance measure from each trial. The list of measures to pool for meta-
analysis was derived by first listing all the balance-related outcome measures described 
in the included trials. This list was then examined and outcomes were placed in order of 
priority, with higher priority given to those outcomes the author considered to be the 
most global measures of balance or balance-related activity performance. The meta-
analysis of this primary outcome measure did show that exercise and motor training can 
improve balance-related activity performance. The Berg Balance Scale26 was given top 
priority in this list, and the meta-analysis of the Berg Balance Scale on its own (as a 
secondary outcome measure) showed a strong trend toward improvement after 
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intervention.  The failure of the meta-analysis on the Berg Balance Scale to reach 
statistical significance is likely to be related to the high level of heterogeneity in the 
analysis, which may have been because only two of these trials included highly-
challenging balance exercises. These results suggest that outcome measures that assess 
balance globally may be more useful for assessing the effects of intervention on balance 
in people with Parkinson’s disease. 
 
While it appears likely that exercise can reduce fall risk in Parkinson’s disease, the 
effect of exercise on actual falls remains unclear. Few randomised controlled trials have 
reported the effect of exercise on falls in people with Parkinson’s disease,13, 27, 28 and the 
results of these studies do not provide evidence of an effect on fall rates. Fall risk scores 
and assessments of the effect of exercise on fall risk factors provides useful interim 
information that is likely to give an indication of the effect on falls themselves. The 
randomised controlled trial presented in this thesis (Chapter 2) showed a 7% (not 
statistically significant) reduction in fall risk, evidence for improvement in sit to stand 
time and freezing of gait and a trend towards an improvement in muscle strength.  
Furthermore, the systematic review with meta-analysis found that exercise and motor 
training can improve the performance of balance-related activities in people with 
Parkinson’s disease.  However, this review did not find any evidence that exercise and 
motor training can reduce falls in people with Parkinson’s disease (Chapter 3).  
Ultimately, evidence of exercise leading to a decrease in falls is important to secure 
funds to implement ongoing exercise programs designed to reduce falls in this 
population.  Further research is required to determine if the reduction in fall risk and 
improvement in fall risk factors reported in this thesis can translate into actual falls 
prevented.  The study presented in Chapter 2 of this thesis has informed the 
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development of a larger trial, currently in progress, designed to determine the effect of 
exercise on falls in people with Parkinson’s disease as well as the cost effectiveness of 
the exercise program from the health provider’s perspective.29 
 
There appears to be a dose-response relationship between exercise and falls in the 
general older population.30  However, no evidence of such a relationship was found 
between the dose of exercise and motor training and improvement in balance-related 
activities in people with Parkinson’s disease (Chapter 3).  This finding may have been 
due to the overall low dose of intervention prescribed in the trials included in the meta-
analysis (average 18 hours).  Future research is needed to examine the effect of using a 
higher dose of intervention on the performance of balance-related activities. 
 
People with Parkinson’s disease require exercise programs that are not only effective, 
but are pragmatic, safe and sustainable. The work presented in this thesis provides 
evidence that people with Parkinson’s disease who have fallen or who are at risk of 
falling are able to exercise safely at home (with the assistance of carers when needed) 
using a pragmatic, minimally-supervised exercise program that targets potentially 
remediable risk factors for falls (Chapter 2). However, caution must be taken when 
applying these results clinically. The randomised controlled trial presented in this thesis 
included only participants who had sufficient cognition, whose Parkinson’s medications 
were stable and who did not have a co-existing medical condition that could make 
independent exercise unsafe. Furthermore, participants were monitored monthly and 
changes to their program (progressions or regressions) made accordingly. Therefore, 
while therapists can be encouraged that carefully designed home-based exercise 
programs can be prescribed for many people with Parkinson’s disease, care needs to be 
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taken to ensure that the program is regularly reviewed and that the person with 
Parkinson’s disease and their carer will be safe. The use of such pragmatic, sustainable 
exercise programs is important given the ongoing, degenerative nature of Parkinson’s 
disease and the limitations of healthcare systems. 
 
Effective yet safe balance exercises are particularly difficult to prescribe in a home-
based, minimally-supervised program. The results of the systematic review and meta-
analysis (Chapter 3) found that highly-challenging balance training is likely to result in 
the best improvements in the performance of balance-related activities in people with 
Parkinson’s disease. Such exercises involve movement of the centre of mass, narrowing 
of the base of support and minimisation of upper limb support. Furthermore, reactive 
balance training (responding to unexpected perturbations) may prove beneficial for 
people with Parkinson’s disease.27, 31, 32  Both these types of balance training 
interventions necessitate the individual performing activities at the limit of their ability 
to balance, and so if not performed carefully with the correct equipment or supervision, 
will place the individual at risk of falling. This tension between the need for home-based 
balance training to be challenging yet safe may explain the lack of improvement in 
standing and leaning balance found in the randomised controlled trial (Chapter 2). While 
the balance training component of the trial was designed to be highly-challenging, the 
results suggest that participants did not perform it at a high enough level of difficulty to 
affect an improvement. The need for balance training to be challenging yet safe and 
sustainable poses a difficult issue which requires further investigation. Future trials 
providing more supervision of the exercise program and/or monitoring of the level of 
perceived challenge when performing balance exercises may help to clarify the 
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challenge of balance exercise and the association between challenge and the amount of 
improvement, and may be the first step forward in solving this issue. 
 
This thesis also identifies reduced muscle power as a new risk factor for reduced 
mobility and falls, which may be amenable to remediation (Chapters 4 and 5).  Muscle 
weakness is not usually apparent during routine clinical examination of people with 
Parkinson’s disease.33, 34  However, the descriptive study presented in Chapter 4 shows 
that people with Parkinson’s disease are likely to have appreciably reduced leg muscle 
power and strength.  Furthermore, it appears that leg muscle power and strength are 
important determinants of walking speed and falls in this population (Chapter 5). Of the 
two measures, muscle power was found to be more strongly associated with both 
walking speed and falls history than muscle strength. For this reason, a Parkinson’s 
disease fall risk score that includes leg muscle power instead of strength warrants 
examination and the effect of muscle power training in this population warrants 
investigation.  
 
In the general older population, muscle power training (high velocity, lower resistance) 
has been found to improve physical performance35, 36 and balance37 as well as to 
increase movement velocity.33  People with Parkinson’s disease have been shown to 
increase muscle strength with appropriate progressive resistance exercise.32, 38-42  
Similarly the randomised controlled trial presented in Chapter 2 showed a trend towards 
an increase in knee extensor muscle strength after strength training with weighted vests. 
However, the descriptive study presented in Chapters 4 and 5 showed that people with 
Parkinson’s disease have reduced leg muscle power which, when lifting light to 
moderate loads, was associated with reduced movement speed. Moreover, this reduced 
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muscle power was found to explain as much or more of the variation in walking 
velocity, and was more strongly associated with past falls, than muscle strength. While 
muscle strength training would be likely to improve muscle power by virtue of an 
improvement in strength, power training also has the potential to increase movement 
velocity (ie, reduce bradykinesia) and so further increase muscle power. Therefore, 
further research is needed to determine the effect of muscle power training on people 
with Parkinson’s disease, particularly on balance impairment, performance of balance-
related activities, movement velocity and falls. If muscle power training with specialised 
equipment is found to be beneficial for people with Parkinson’s disease, then more 
clinically-accessible techniques for measuring and training muscle power in this 
population will need to be explored. Leg muscle power has been successfully measured 
in the general older population using a stair climbing protocol which is likely to be 
suitable for people with Parkinson’s disease,43 and home-based muscle power training 
could be trialled using the weighted vests that were found to be safe for home-based 
strength training. 
 
The measurement of muscle power allows for the separate recording of muscle force and 
speed of muscle contraction, and so provides information about the influence of 
bradykinesia during rapid muscle contractions. The descriptive study presented in 
Chapter 4 found that muscle power measures taken with light to medium loads appear to 
be affected by decreased movement speed (bradykinesia), while power measures taken 
with heavy loads appear to be unaffected. This apparent absence of bradykinesia when 
lifting heavy loads could be further explored by recording muscle electromyography 
during power testing to determine if the abnormalities associated with bradykinesia 
change with different loads. Alternatively, it could be explored by measuring muscle 
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power using randomly varying loads. In the descriptive study presented in Chapter 4, 
participants knew that the load was increasing with each subsequent lift. This may have 
resulted in a subconscious increase in volitional drive when lifting the heavy loads, 
resulting in a situation similar to that seen in paradoxical kinesia where individuals are 
able to increase their movement speed under extreme circumstances. Improved 
understanding of the relationship between muscle strength, muscle power and 
bradykinesia has the potential to inform and enhance exercise interventions for this 
population, particularly in the areas of falls prevention and balance, where the ability to 
use muscles quickly is paramount. 
 
FINAL REMARKS 
Overall, the studies presented in this thesis provide promising evidence that fall risk in 
people with Parkinson’s disease is likely to be reduced through appropriately designed 
exercise interventions.  Moreover, reduced leg extensor muscle power is probably an 
important, previously unconsidered, risk factor for falls in this population. These results 
provide important information to assist clinicians and researchers when designing 
exercise interventions for people with Parkinson’s disease who are at risk of falling.  It 
is now important to assess the effect of exercise interventions on fall rates and to further 
develop effective, sustainable programs that people with PD can participate in for the 
long term.  Any reduction in falls in this group will improve the quality of life of people 
with Parkinson’s disease and their carers and help to reduce pressures on healthcare 
systems. 
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Balance in Parkinson’s disease 
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BALANCE IMPAIRMENT 
The underlying mechanisms underlying balance impairment in Parkinson’s disease are 
complex and remain unclear.  Traditionally, reduced balance in Parkinson’s disease was 
thought to be due to erroneous motor programming of postural corrections within the 
basal ganglia.1  However, recent work has found central somatosensory deficits which 
may also contribute to reduced balance.2-4  In fact, people with Parkinson’s disease have 
been found to have a tendency to overestimate the distance they can reach forwards 
without losing their balance.5  It may be that somatosensory deficits lead to an abnormal 
perception of body position, resulting in individuals with Parkinson’s disease 
overestimating their limits of stability and so contributing to an increased likelihood of 
falling.1, 5 
 
Balance impairment in Parkinson’s disease is often described and assessed in terms of 
the individual’s response to perturbations (eg in the Unified Parkinson’s Disease Rating 
Scale (UPDRS) motor score).6  However, the impact of Parkinson’s disease on balance 
in standing is broader and more variable than that and can be considered under three 
circumstances: while standing (ongoing postural adjustments); during volitional 
movement (anticipatory and ongoing postural adjustments) and in response to a 
perturbation (reactive postural adjustments). 
 
Standing 
Balance while standing is often measured by postural sway.  In neurologically-normal 
adults, postural sway increases with age7 and amongst the older population, fallers sway 
more than non-fallers.8, 9 
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Studies of postural sway in people with Parkinson’s disease have yielded inconsistent 
results.  Most studies have found an increase in sway compared with healthy control 
groups, with sway in the mediolateral direction seeming to be more affected than 
anteroposterior sway.10-15  Additionally, the increase in sway that occurs under eyes 
closed compared to eyes open conditions has been found to be greater in people with 
Parkinson’s disease than healthy controls.10  Other studies, however, have reported 
similar postural sway in people with and without Parkinson’s disease.16, 17  This 
discrepancy is likely to be due to differences in medication status, disease severity and 
testing procedures. 
 
Medication status has been shown to affect postural sway measures, with an increase in 
sway observed in the ON state.14, 18, 19  The simplest explanation for increased sway in 
the ON state is the presence of dyskinesia.  A study of the postural sway of 11 people 
with advanced Parkinson’s disease and levodopa-induced dyskinesia19 found a 125% 
increase in net centre of pressure displacement when participants were ON with 
dyskinesia compared to when they were OFF.  However, increased sway when ON has 
also been reported in people with Parkinson’s disease who do not experience dyskinesia.  
Maurer et al (2003)14 measured postural sway and intersegmental upper body-lower 
body stiffness in eight people with Parkinson’s disease without levodopa-induced 
dyskinesia.  Results showed increased sway but decreased intersegmental stiffness when 
participants were ON compared to OFF.  The authors suggested that levodopa reduced 
rigidity, and in doing so revealed a balance impairment which was not responsive to 
levodopa.   
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The suggestion that postural sway might be reduced by rigidity when OFF medication 
has support from previous work.  A study of eight people with moderate to advanced 
Parkinson’s disease tested OFF medication found a smaller postural sway area in the 
Parkinson’s disease group compared to healthy controls.20  Furthermore, postural 
stiffness in standing has been found to correlate with postural instability.21  Medication 
status, therefore is likely to affect postural sway, particularly in individuals with marked 
rigidity and/or who experience levodopa-induced dyskinesias.  Accordingly, an 
abnormal increase or decrease in postural sway may be evident in people with 
Parkinson’s disease. 
 
Despite studies of postural sway in Parkinson’s disease yielding variable results, 
increased postural sway has been found to be related to increased disease severity and 
increased fall risk.10-13, 22  Recent work13 examined people with Parkinson’s disease at 
different stages of the disease process while OFF their medication. Results showed 
participants with more advanced disease had increased sway, while those with early 
disease who had never used dopaminergic medication exhibited normal postural sway.  
Another study compared the postural sway of people with Parkinson’s disease who had 
fallen with those who had not fallen.22  The fallers were found to have more sway in 
both the mediolateral and anteroposterior direction than the non-fallers, under eyes open 
and eyes closed testing conditions.  Furthermore, increased postural sway was found to 
be an independent risk factor for falls in this study.   
 
As Parkinson’s disease severity increases, individuals tend to stand with a narrow base 
of support and a flexed posture.23, 24  The reason why individuals with Parkinson’s 
disease adopt body postures which would ostensibly increase their instability is unclear, 
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however recent work suggests that these postures may compensate for difficulty 
initiating walking.25, 26   
 
A narrow base of support is inherently more unstable than a wider one, however people 
with Parkinson’s disease typically stand and walk with the feet close together.27  When 
healthy adults are perturbed while standing with feet close together, they modify the size 
and direction of postural forces produced.  In contrast, people with Parkinson’s disease 
are less likely to make these modifications,28 further increasing their risk of falling.  
However, people with Parkinson’s disease have been shown to have more difficulty 
initiating a step from wide stance (feet shoulder width apart) than from narrow stance, 
due to difficulty making a large enough anticipatory postural adjustment.25  This 
suggests that the narrow base of support adopted by people with Parkinson’s disease 
may be a compensatory strategy for difficulty shifting their weight laterally to step.25  
 
Standing with a flexed posture is associated with a forward shift in the centre of foot 
pressure in people with moderate to severe Parkinson’s disease.10, 17  Furthermore, the 
magnitude of this forward shift increases with disease severity.10, 17  Surprisingly, 
however, the centre of foot pressure is shifted backwards in people with mild disease.17  
This backwards shift is likely to have a destabilising effect and predispose the individual 
to losing balance backwards.  It has been suggested that the forward shift in centre of 
foot pressure and hence the flexed posture seen later in the disease may, therefore, be an 
adaptive response to prevent falling backwards.10, 17  
 
It appears however, that standing with a flexed posture is intrinsically unstable and so 
may contribute to reduced balance in Parkinson’s disease.26  Bloem et al (1999)29 
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investigated the responses of healthy people to toe-up rotational perturbations while 
mimicking a Parkinsonian flexed posture.  Results showed that a flexed posture did 
minimise the backwards excursion of the centre of mass in response to this type of 
rotational perturbation.  However, a similar experiment by Jacobs et al (2005)26 
analysed responses to multidirectional horizontal perturbations.  They reported that a 
flexed posture decreased postural stability in healthy people.  The authors suggested that 
the discrepancy between this and Bloem et al’s (1999)29 result was due to the context-
specific nature of postural responses.  Specifically, for a toe-up rotation, a flexed posture 
would improve stability as knee flexion would reduce the stretch on the gastrocnemius 
muscle and so reduce the amount of (destabilising) reflexive plantar flexion.26, 29  In 
contrast, a flexed posture may hinder responses to horizontal perturbations as it may 
make it more difficult to relocate the centre of mass over a shifted base of support.26  
The authors speculated that flexed posture, similar to a narrowed base of support, may 
be a compensatory strategy to aid step initiation by facilitating forward movement of the 
centre of mass.26  
 
Volitional Movements 
Volitional movements require anticipatory postural adjustments to be made to stabilise 
the body’s centre of mass over the base of support, or to move it over a new base of 
support.30-32  In healthy adults, the size and timing of these postural adjustments appear 
to be proportionate to the anticipated magnitude of the destabilising force.30  
 
Anticipatory postural adjustments in Parkinson’s disease appear to be normal in terms of 
the general sequence of muscle activations.33-36  However, abnormalities have been 
found in terms of the timing, speed and size of muscle activations.  When rising onto the 
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toes, both people with Parkinson’s disease and neurologically-normal people first 
contract the tibialis anterior (to move the body mass forward) and quadriceps (to 
stabilise the knee) in order to prepare for the gastrocnemius muscle to raise the heels.33  
However, the relative timing of the tibialis anterior and gastrocnemius contractions has 
been found to be more variable and less forceful in people with Parkinson’s disease than 
in neurologically-normal people, resulting in a slower, less forceful postural adjustment 
and less stability while balancing on the toes.36  Similar results have been found with 
rapid arm raising tasks, with anticipatory postural adjustments prior to raising the arm 
inconsistently present and small compared to healthy adults.34, 37-39  
 
It has been suggested that these inconsistent and small adjustments seen prior to rapid 
arm rising may simply be because the individuals with Parkinson’s disease were moving 
their arm more slowly.34, 37, 38  Indeed, the presence and timing of postural adjustments 
have been shown to be dependent on the speed of the arm lift.  When the arm is lifted 
rapidly, postural muscles are activated in a consistent sequence.  Even in normal adults, 
when the arm is lifted slowly, the sequence of muscle activation is more variable and 
some postural muscles do not show activity at all.30  This is likely to be because less 
stabilisation force is required during slow movements.30 
 
While people with Parkinson’s disease do tend to move more slowly than normal adults, 
they continue to display small postural adjustments even when rapid movement speed is 
achieved.39  Postural adjustments in preparation for rapid arm rising were studied in 10 
people with relatively mild Parkinson’s disease while OFF medication.  Results showed 
anticipatory postural adjustments were consistently present, but were smaller than the 
healthy control group.  This was despite the fact that the Parkinson’s disease group did 
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not have reduced movement speed or duration.39  Therefore, even when the speed and 
size of the movement were accounted for, the size of the postural adjustment was 
reduced, suggesting that small postural adjustments in Parkinson’s disease are not 
entirely due to slow movement speed.  
 
Self initiated stepping tasks, both in forwards25, 40-42 and sideways directions,43 have also 
been used to assess anticipatory postural adjustments in people with Parkinson’s 
disease.  These studies have shown small and slow postural adjustments25, 40-44 along 
with shorter steps25, 40, 44 in people with Parkinson’s disease compared to healthy 
controls.  Furthermore, people with Parkinson’s disease have been shown to have 
reduced propulsive force production during postural adjustments prior to stepping, 
particularly when OFF medication.40  These small and slow adjustments are likely to 
have delayed unloading of the swing leg and so contributed to the reduced step length.40  
Overall, it therefore appears that bradykinesia influences the size and speed of postural 
adjustments in preparation for movement as well as the size and speed of the intended 
movement. 
 
External Perturbations 
A significant threat to balance occurs when there is an unexpected external perturbation.  
Most of the research that has looked at the effect of external perturbations in people with 
Parkinson’s disease has analysed responses to movement of the support surface on 
which participants are standing.  In considering these results, therefore, it is important to 
bear in mind that these types of perturbations may evoke different responses to the 
pushes or bumps that are more commonly encountered in daily life. 
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Much work has focused on responses of the muscles around the ankles which serve to 
maintain stability.  These responses are reflexive as they occur earlier than voluntary 
reaction times would allow, regardless of whether or not the perturbation was 
predictable.45  Neurologically-normal adults standing on a moveable platform display 
stereotypical, but modifiable reflex responses to platform perturbations.46-48  If the 
platform remains horizontal, but moves backwards, the resultant increase in dorsiflexion 
stretches the calf muscles, eliciting a short and medium latency reflex contraction in 
those muscles, which serves to stabilise the person.  These muscle contractions around 
the ankle are then followed by muscle contractions in more proximal muscles, with 
muscles contracting in a distal to proximal sequence with minimal co-contraction.47  If a 
rotational toe-up perturbation is used to achieve the dorsiflexion, then the calf muscles 
will still contract in response to the stretch.  However, under this condition the calf 
muscles contraction is destabilising, and so is followed by a longer latency contraction 
in the tibialis anterior muscle in order to maintain balance.46, 48  Furthermore, repeated 
trials of rotational perturbations lead to a diminished contraction response in the calf 
muscles, hence normal reflex responses are modulated to produce a more efficient way 
of responding to the perturbation.46 
 
When people with Parkinson’s disease are subjected to unexpected external support 
surface perturbations, most show similar muscle activation latencies to that of 
neurologically-normal adults17, 23, 48-52  Loss of balance is, therefore not due to a delayed 
response, but an ineffective response.20  These responses have several distinguishing 
features, including increased size of destabilising responses, inflexibility of response 
and excessive co-contraction of agonist and antagonist muscles. 
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Research has consistently found abnormalities in the size of reflex responses in the leg 
muscles of people with Parkinson’s disease.  When people with Parkinson’s disease are 
subjected to a rotational toe-up perturbation, they exhibit an enlarged destabilising reflex 
contraction of the stretched calf muscles.17, 23, 53-55  Furthermore, the size of these reflex 
contractions has been found to correlate with disease severity, with the largest 
abnormality in people with more advanced disease.23  These reflex contractions are 
especially large in response to the first perturbation, and so may underlie falls from 
unexpected postural disturbances in people with Parkinson’s disease.27, 56  Less 
consistently, some studies have also found a reduction in the stabilising response of the 
anterior tibial muscles, which would further exacerbate the tendency to fall.54, 55 
 
Much work has shown the postural reflex responses of people with Parkinson’s disease 
to be inflexible, even when ON medication.  When sitting, there is normally no reflex 
response in the anterior tibial muslces in response to rapid ankle dorsiflexion, as it is not 
required to maintain balance.57  In contrast, reflex contraction in the anterior tibial 
muscles has been shown to occur in seated people with Parkinson’s disease.58  People 
with Parkinson’s disease are also unable to modify their postural responses to 
perturbations when standing on a narrow beam or when sitting on a high stool compared 
to when standing on a flat surface, while healthy adults change their strategy to use 
more proximal muscles.20  Furthermore, people with Parkinson’s disease have been 
found to be slower than healthy adults to change postural responses when perturbation 
characteristics change (toes-up vs backward horizontal perturbation),59 or when 
instructions change (“give in to” or “resist” the perturbation).55, 59  Moreover, when 
allowed to hold on with the hands during a perturbation in standing, healthy adults 
suppress medium and long latency ankle muscle activations, while people with 
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Parkinson’s disease do not.17  It seems, therefore, that people with Parkinson’s disease 
are less able to modulate their postural reflex responses to suit different body positions, 
tasks or environmental situations.27 
 
Excessive abnormal co-contraction of agonist and antagonist postural muscles in 
response to external perturbations has been consistently found in people with 
Parkinson’s disease.20, 23, 48-50  Specifically, antagonist muscles tend to be activated too 
early and with excessive magnitude resulting in co-contraction rather than reciprocal 
contraction of agonist and antagonist postural muscles in the legs and trunk.48-50  People 
with Parkinson’s disease also have excessive background muscle activity,48-50 which 
may reflect compensatory stiffening due to fear of falling.48, 50  Furthermore, the rigidity 
of Parkinson’s disease may interfere with the intrinsic ability of muscles to dampen 
body sway.23, 60, 61  These factors all contribute to increased postural stiffness in people 
with Parkinson’s disease.50   
 
This postural stiffness is likely to contribute to falls in people with Parkinson’s disease.  
Stiffening has the advantage that it helps to maintain the centre of mass within a small 
area, reducing the risk of exceeding the limits of stability,20, 62 and may somewhat 
improve resistance to external perturbations.49  On the other hand, the increased stiffness 
reduces the visco-elastic properties of the body which normally aid in absorbing 
perturbations27 and impedes rapid generation of muscle torque.36, 49  Furthermore, people 
with Parkinson’s disease have a reduced ability to appropriately increase muscle 
activation when perturbations occur while standing with feet close together,50 and 
bradykinesia reduces the speed at which postural muscle forces are produced.18, 36, 40, 49  
Resultantly, people with Parkinson’s disease with severe balance impairment have very 
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small limits of stability, and exceeding these limits is likely to result in the individual 
falling like a log.20, 27   
 
Taking a step is a common reaction to a threat to stability, and if the centre of mass is 
perturbed outside of the limits of stability, compensatory stepping is crucial in 
preventing a fall.63  The compensatory steps of people with Parkinson’s disease have 
been found to be later, slower and shorter than neurologically-normal people of the same 
age.52, 64  These abnormalities appear to be associated with bradykinesia64 and would 
reduce the chances of the person with Parkinson’s disease successfully recovering their 
balance and averting a fall.   
 
Recent work has suggested that people with Parkinson’s disease have difficulty 
initiating compensatory steps.  King and Horak (2008)64 studied the stepping responses 
to a lateral platform perturbation in 13 people with Parkinson’s disease compared with a 
neurologically-normal control group.  Results showed that the control group were 
consistently able to take successful compensatory steps to avoid a fall, but the 
Parkinson’s disease group “fell” in 24% of trials when ON medication and 35% of trials 
when OFF medication.  Two successful stepping strategies were observed: a side step 
with the leg on the opposite side to the perturbation in order to widen the base of 
support; or a crossover step with the leg un-weighted by the effect of the perturbation.  
The side step was the most commonly used strategy in both groups.  This strategy 
requires the individual to rapidly increase the vertical force under the stepping leg in 
order to unload it by shifting the centre of mass toward the stance leg.  Moreover, this 
needs to be accomplished at a time when the perturbation itself is tending to load the 
stepping leg and unload the stance leg.  Results showed that the healthy control group 
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were able to consistently achieve this lateral weight shift prior to stepping.  In contrast, 
only half the participants in the Parkinson’s disease group used a lateral weight shift 
prior to stepping, and most of these individuals were not able to use the strategy 
consistently.  Furthermore, trials where there was an absence of lateral weight shift were 
associated with a “fall”.  This suggests that some participants with Parkinson’s disease 
had difficulty generating the lateral weight shift required to initiate successful 
compensatory stepping. 
 
King and Horak’s (2008)64 study also provides evidence that people with Parkinson’s 
disease can have difficulty selecting appropriate and consistent postural responses.  
Participants in the healthy control group consistently used either the side step or 
crossover step strategy, whereas many participants in the Parkinson’s disease group 
changed strategy from trial to trial, or used a different strategy when OFF as compared 
to ON.  It was these participants who had the highest “fall” rates, falling on 57% to 
100% of trials.  Furthermore, some participants with Parkinson’s disease used strategies 
that were often unsuccessful.  Two Parkinson’s disease participants failed to step at all 
and fell like a log.  The remaining participants most often used a side stepping strategy, 
resulting in falls in 17% of trials when OFF medication.  However, when a crossover 
step strategy was used, falls occurred in 75% of trials when OFF medication.  
Furthermore, in some trials the participant first took a very small side step, followed by 
a crossover step and then a “fall”.  The authors proposed that this variability in response 
suggests that people with Parkinson’s disease may have difficulty pre-selecting a 
consistent strategy, resulting in a delayed or inadequate response, and consequently 
more falls. 
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Balance impairment in Parkinson’s disease is therefore complex and multifaceted. 
Overall, the postural adjustments of people with Parkinson’s disease tend to be variable, 
delayed, slow and small, combined with reflex responses that can be destabilising and 
inflexible. Furthermore, while balance impairment is a cardinal sign of Parkinson’s 
disease, it also appears to be influenced by other impairments including bradykinesia 
and rigidity. For most people with Parkinson’s disease, balance impairment will worsen 
as the disease progresses. It is therefore an important risk factor for falls in this 
population. 
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FREEZING OF GAIT 
People with Parkinson’s disease who experience freezing of gait often report that they 
feel that their feet are ‘glued’ to the floor and they are unable to start or continue 
walking.1-3  The most common manifestations of freezing of gait are moving forward 
with very small steps and leg trembling with no effective forward movement.4  Freezing 
of gait usually occurs when the person with Parkinson’s disease is in the OFF state, 
though ON state freezing does occur in some people.5  Complete akinesia with no 
observable movement of the legs is less common and more likely to occur when OFF 
medication.4   
 
Freezing of gait is associated with disease progression and significantly contributes to 
disability and falls in people with Parkinson’s disease.  Freezing in early disease is 
usually brief, causing only mild difficulty and rarely leading to falls.2, 4  However, as the 
disease progresses, freezing occurs more often and for longer, lasting up to a minute or 
more.6  This can lead to restriction of physical activity and limited walking in the 
community.7  Furthermore, as freezing episodes tend to be sudden and unpredictable, 
and as many people with Parkinson’s disease have impaired balance, freezing can often 
disturb balance enough to result in a fall.1-3, 8   
 
It is well recognised that freezing of gait can be exacerbated by environmental, task and 
emotional constraints.7  People with Parkinson’s disease are more likely to freeze in 
environments which appear busy (eg, in a crowd), or are restricted in space (eg, a 
narrow doorway or a cluttered room.2, 7, 9  Long or complex tasks, or performing a 
second task while walking, can trigger a freezing episode in some people.1, 2, 10  Stressful 
situations (eg, crossing a busy road) and anxiety also make freezing worse in people 
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who are prone to this problem.7, 11  Conversely, moderate emotional stress in situations 
where people can focus their attention on walking (eg at the doctor’s office) can 
improve freezing.11  This fact makes freezing of gait a difficult impairment to assess, 
treat and research. 
 
Gait Abnormalities Associated With Freezing of Gait 
The underlying mechanisms responsible for freezing of gait are unclear.12  Freezing of 
gait does not appear to be due to bradykinesia or rigidity.3  However, several gait 
abnormalities are suggested to be associated with freezing episodes.  These include 
hypokinesia,7 gait festination,7 difficulty linking postural adjustments with stepping,13 
and abnormalities of rhythmicity, symmetry and coordination.14  
 
Gait hypokinesia has been suggested to contribute to freezing, particularly during gait 
initiation.7  Hypokinesia refers to reduced amplitude of movement.  Gait hypokinesia is 
a common characteristic in people with Parkinson’s disease, and has been found to be 
due to an abnormality in the regulation of stride length.15  Specifically, for a given 
speed, people with Parkinson’s disease walk with a shorter stride length and a higher 
cadence than healthy adults.  Furthermore, when required to walk at a specific cadence, 
stride length remains short, resulting in slowed walking speed.15  This is thought to be 
due to a mismatch between movement amplitude selected by the cortex and the actual 
size of lower limb movements during walking.16  As the preferred walking speed of 
people with Parkinson’s disease is slower than normal, gait hypokinesia leads to slow, 
short stepped walking.15  When severe, movement amplitude is scaled down so far that 
step initiation fails to occur, resulting in a freezing episode.7  The small and slow 
postural adjustments which impede the weight transference required to unload the swing 
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leg prior to self-initiated stepping13, 17-21 provides evidence for the involvement of gait 
hypokinesia in freezing during gait initiation.7 
 
Gait festination has been suggested to contribute to freezing during a walking sequence.7  
Gait festination refers to a progressive shortening of stride length associated with a high 
cadence and reduction of walking speed.7, 22  An exponential increase in cadence along 
with a decrease in stride length has been found to occur during both festination and in 
the three steps prior to freezing, suggesting that some freezing episodes may be due to a 
combination of an inability to maintain stride length and control cadence.22  This is 
thought to be due to abnormalities in the timing of motor cue production in the globus 
pallidus, with freezing occurring when these phasic cues become very slow or absent.7, 
23  Freezing associated with festination therefore occurs when steps during walking 
become increasingly shorter and faster, ultimately resulting in a freezing episode.7, 23  
 
It is likely that hypokinesia and festination occur together for some people who 
experience freezing.7, 23  “Frozen” gait (likely to be festination)22 has been associated 
with an incomplete weight shift from one foot to the other.24  This is similar to that 
attributed to hypokinesia7 during self-initiated stepping.13, 17-21  It therefore seems 
possible that hypokinesia may be exacerbating festination in some people.23 
 
Recent work has provided evidence that freezing associated with a forward loss of 
balance may due to an inability to combine postural adjustments with stepping.13  Jacobs 
et al (2009)13 compared the postural adjustments in response to a forward loss of balance 
in 10 people with Parkinson’s disease and marked freezing problems with 10 healthy 
adults.  Results showed that the healthy people usually responded with one weight-
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shifting postural adjustment, followed by a step.  In contrast, people with Parkinson’s 
disease exhibited multiple postural adjustments in 69% of trials when OFF medication 
and in 40% of trials when ON medication.  These trials with multiple postural 
adjustments were associated with freezing (ie, late step onset or no step followed by a 
fall), along with alternating trembling of the knees.  However, the multiple postural 
adjustments were not delayed in onset and the weight shift was of normal size, 
suggesting that these freezing episodes were not caused by hypokinesia.  The authors 
propose that the leg trembling often seen during freezing episodes is due to multiple 
postural adjustments and that when freezing is associated with a forward loss of balance 
it may be due to an inability to link a normal postural adjustment to the motor pattern for 
stepping.13   
 
The gait of people with Parkinson’s disease who experience freezing is less rhythmic, 
less symmetric and less coordinated than the gait of those who do not freeze.14  While 
hypokinesia, festination and difficulty linking postural adjustments with stepping can be 
observed at or near the time of the freezing episode, problems with rhythmicity, 
symmetry and coordination are apparent even between freezing episodes.14  This 
suggests that freezing may be an extreme form of this disturbed gait pattern.2  
Alternatively, these gait disturbances may predispose an individual to freezing by 
making it more likely that another disturbance (eg, cognitive loading) will exacerbate 
the already disturbed gait and so trigger a freezing episode.14  Whatever the relationship 
between these gait disturbances and freezing, it seems that those people with 
Parkinson’s disease who have reduced coordination of their left to right stepping pattern 
are more prone to freezing.14 
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Gait rhythmicity is typically assessed by measures of stride-to-stride variability.  The 
stride-to-stride variability of people with Parkinson’s disease has been found to be 
higher than healthy adults,25 even in the early stages of the disease.26  However, people 
with Parkinson’s disease who experience freezing of gait have even higher levels of 
stride-to-stride variability than those who do not freeze.27  This difference in variability 
between freezers and non-freezers is apparent even when the two groups are similar in 
terms of average stride time, cadence and clinical characteristics.27  Interestingly, high 
stride variability is also associated with falls in people with Parkinson’s disease.28  As 
freezing of gait is associated with falls as well, it seems possible that there may be one 
pathological mechanism contributing to the two problems.2 
 
Gait asymmetry (a comparison of the swing time of each leg)29 and bilateral 
discoordination (coordination between left and right stepping phases)30 have also been 
found to be increased in people with Parkinson’s disease who freeze, compared to those 
who do not.14, 29, 31  Furthermore, these impairments in the bilateral function of gait have 
not been found to be related to asymmetry in Parkinson’s disease symptoms.29, 31  
Notably, freezing of gait is common during gait initiation and turning,28 both of which 
require the left and right legs to be used in an asymmetric manner.14  Reduced symmetry 
and bilateral coordination may therefore predispose some people to freeze during these 
tasks.14 
 
In summary, freezing of gait is a debilitating and frustrating symptom of Parkinson’s 
disease for which the underlying mechanism is unclear. The intermittent, sudden and 
unpredictable nature of freezing means that freezing episodes place an extra challenge 
on the individual’s ability to balance. Given that many people with Parkinson’s disease 
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have impaired balance, freezing of gait can instigate falls and so is an important risk 
factor for falls in this population. 
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The Weight-bearing Exercises for Better Balance exercise program (WEBB) is designed 
to be a challenging, safe, evidence-based physiotherapy program for older people.  The 
randomised controlled trial presented in this thesis used the Parkinson’s disease version 
of the WEBB (PD-WEBB), which included cueing strategies to reduce freezing in 
Parkinson’s disease.  
 
The WEBB was developed by Dr Catherine Sherrington, Dr Colleen Canning, Dr 
Catherine Dean, Ms Natalie Allen (the PhD candidate) and Ms Karyn Blackman. 
 
For easy reference, an abridged version of the PD-WEBB has been included in this 
appendix. For full details, please refer to the website at: http://webb.org.au/. 
 
The cueing intervention used in this study was based on that used in the RESCUE trial.1 
Details of the cueing intervention varied according to the needs of each participant. 
Trainers referred to the following resources when planning cueing interventions: 
 
1 Nieuwboer A, Kwakkel G, Rochester L, Jones D, Van Wegen E, Willems A, 
Chavret F, Hetherington V, Baker K, Lim I (2007) Cueing training in the home 
improves gait-related mobility in Parkinson's disease: The RESCUE trial. 
Journal of Neurology, Neurosurgery and Psychiatry 78: 134-140. 
2 RESCUE Consortium (2005) Using cueing to improve mobility in Parkinson’s 
disease. A CD-Rom for therapists. 
[http://hces.unn.ac.uk/rescue/pubs/cd-rom.htm] 
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FREEZING INFORMATION SHEET 
 
“Freezing” is the word used to describe a sudden difficulty in starting or continuing a 
movement. People report feeling as though they are frozen, or that their feet are stuck to 
the ground. 
 
Using cues is thought to help prevent freezing and to end a freezing episode. Cues are 
prompts that help people to move. They usually provide information about the 
 timing (eg, stepping to metronome beat, counting) or 
 size (eg, strip of tape on the floor to step over) 
of the next movement. 
 
Common times for freezing and some suggested strategies to overcome it are given 
below. 
 
 
Taking the first step to start walking 
 Shift your weight from side to side so you are rocking between your right and 
left leg.  
 Count to yourself as you rock, and start walking on a particular number you have 
chosen. 
 Use a metronome beat to rock with and then start walking on the beat. 
 Step over a stripe or other object on the floor (if you regularly freeze in the same 
place, you could put a strip of tape on the floor there). 
 Try to step into an uncrowded space. 
 If shifting from side to side is not successful, try taking a step back or to the side, 
then step forwards. 
 
 
Walking in a confined space (eg, doorway, between 2 chairs) 
 Start counting to yourself a few steps before hand and keep stepping with your 
counting rhythm. 
 If you feel you are beginning to freeze, then STOP.  Use the strategies above to 
get started again. 
 Take steps in time to a metronome to help you keep your rhythm. 
 Step very deliberately or stamp your feet. 
 Place strips of tape on the floor, step width apart, in places where you regularly 
freeze. Step over each strip of tape as you walk. 
 Place a single strip of tape in doorways and focus on stepping over the tape. 
 
 
Turning from a stationary start (eg, from kitchen bench) or in confined spaces 
 Turn using a clock-like motion. 
 Step around with high steps, keep feet apart, do not swivel. 
 Count to yourself as you begin stepping on the spot, and maintain the stepping 
rhythm throughout the turn. 
 Take steps in time with a metronome to help you keep your rhythm. 
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Turning when walking 
 Turn in an arc using big steps. 
 Start counting to yourself a few steps before the turn and keep stepping with 
your counting rhythm. 
 Take steps in time to a metronome to help you keep your rhythm. 
 Step very deliberately or stamp your feet as you turn. 
 Place strips of tape on the floor, step width apart, in places where you regularly 
freeze when turning. Step over each strip of tape as you turn. 
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Form of Manuscripts 
The text of the manuscript should be in the following sequence: (1) Title page, (2) 
Abstract, (3) Introduction, (4) Methods, (5) Results, (6) Discussion, (7) 
Acknowledgment, (8) Authors' Roles, (9) Financial Disclosures of all authors (for the 
preceding 12 months), (10) References, (11) Video Legend, (12) Figures, and (13) 
Tables. Pages should be numbered in succession, the title page being one. 
Title: Titles should be short, specific, and clear. They should not exceed 100 characters. 
Do not use abbreviations in the title. 
Title Page:The opening page of each manuscript should include only: (1) article title; 
(2) authors' names and affiliations (indicate the specific affiliation of each author by 
superscript, Arabic numerals); (3) name, address, and telephone and fax numbers of the 
person to whom proofs and reprint requests should be addressed; (4) word count; (5) 
any necessary footnotes to these items; (6) a running title not exceeding 45 letters and 
spaces; (7) Key words; (8) Financial Disclosure/Conflict of Interest concerning the 
research related to the manuscript: All information on support and financial issues from 
all authors relative to the research covered in the submitted manuscript must be 
disclosed regardless of date. Other financial information unrelated to the current 
research covering the past year will be documented at the end of the manuscript (see 
below). Note that submissions without this Financial Disclosure on the Title Page will 
be returned to the author. For clinical trials, a statement on ghost-writing is required 
(Movement Disorders 2005;20:1536). 
Abstract:The page following the title page of Full-Length Articles should include a 
brief abstract of up to 250 words describing the background, methods, results, and 
conclusions of the study. We encourage authors to submit papers with structured 
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abstracts, especially for clinical trial papers. The page following the title page of a Brief 
Report should include a brief abstract of up to 100 words. 
Key words: Up to six key words or terms should be provided following the abstract. 
Introduction: Give a brief description of the background of the scientific contribution. 
Methods:Informed consent: For experimental investigation of human or animal 
subjects, please state in this section that an appropriate institutional review board 
approved the project. For those investigators who do not have formal ethics review 
committees, the principles outlined in the “Declaration of Helsinki” should be followed. 
For investigations in human subjects, state in this section the manner in which informed 
consent was obtained from the subjects. A letter of consent must accompany all 
photographs, patient descriptions, and pedigrees in which a possibility of identification 
exists. The authors are responsible for proper anonymisation of their patients. 
Results: No specific regulations. 
Discussion: No specific regulations. 
Acknowledgment: No specific regulations. 
Author Roles: List all authors along with their specific roles in the project and 
preparation of the manuscript. These may include but are not restricted to: 1) Research 
project: A. Conception, B. Organization, C. Execution; 2) Statistical Analysis: A. 
Design, B. Execution, C. Review and Critique; 3) Manuscript: A. Writing of the first 
draft, B. Review and Critique. 
Full Financial Disclosures of all Authors for the Past Year: Information concerning 
all sources of financial support and funding for the preceding twelve months, regardless 
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of relationship to current manuscript must be submitted with the following categories 
suggested. List sources or “none”. 
  
Stock Ownership in medically-related fields Intellectual Property Rights 
Consultancies Expert Testimony 
Advisory Boards Employment 
Partnerships Contracts 
Honoraria Royalties 
Grants Other 
  
References: See “Details of Style” for the proper formatting of citations and 
References. 
Video Legend: No specific regulations. 
Tables and Figure Legends: Double-space legends of fewer than 40 words for tables 
and figures. For photomicrographs, include the type of specimen, original magnification, 
and stain type. Include internal scale-markers on photomicrographs. Where applicable, 
indicate the method used to digitally enhance images. 
Tables: Tables should be typed neatly, each on a separate page, with a title above and 
any notes below. Explain all abbreviations. Do not repeat the same information in tables 
and figures or tables and text. 
Figures and Illustrations: Adapt any figures to an appropriate size of art and letters to 
make them readable in the printed version. Illustrations in full color are accepted at 
additional charge from the publisher. Any illustration or figure from another publication 
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must be acknowledged in the figure legend, and the copyright holder’s written 
permission to reprint in print and online edition of Movement Disorders must be 
submitted to the editors. 
Copyright and Disclosure Forms The corresponding author should upload one PDF 
file that includes copyright and disclosure forms for all authors to the Movement 
Disorders submission site with the revised version of the paper. These forms also can be 
emailed to mdjedoffice@movementdisorders.org. 
Digital Artwork Preparation 
For best reproduction, electronic artwork files must be in TIFF or EPS format, at a 
resolution of 600 dpi or higher, sized to print. Movement Disorders offers Rapid 
Inspector™ to help ensure that your electronic graphics files are suitable for print 
purposes. This free, stand-alone software application will help you to inspect and verify 
illustrations right on your computer. Go to 
http://rapidinspector.cadmus.com/wi/index.jsp and create a new account. 
Details of Style 
No patient identifiers (e.g., patient initials) are to be included in the manuscript or video 
(e.g., case reports, tables, figures, etc.). 
Units of measure: Conventional units of measure according to the Systeme 
International (SI) are preferred. The metric system is preferred for length, area, mass, 
and volume. Express temperature in degrees Celsius. 
Drug Names: Use generic names only in referring to drugs, followed in parentheses 
after first mention by any commonly used generic variant. 
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Abbreviations: Follow the list of abbreviations given in "Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals" (see section on References). For 
additional abbreviations, consult the CBE Style Manual (available from the Council of 
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